<?xml version="1.0" encoding="UTF-8"?>
<svg height="776.6" width="553.2" xmlns="http://www.w3.org/2000/svg">
 <g>
  <text svgx:width="0.38,0.65,0.43,0.54,0.47,0.65,0.55,0.43,0.32,0.58,0.65,0.55,0.31,0.24,0.37,0.58,0.61,0.47,0.65,0.55,0.31,0.24,0.58,0.39,0.24,0.87,0.55,0.65,0.58,0.96,0.54,0.63,0.32,0.54,0.32,0.65,0.54" y="647.0" x="68.5,71.5,76.8,80.2,84.5,88.3,93.5,97.9,101.3,103.9,108.5,113.8,118.1,120.6,122.5,125.5,130.1,135.0,138.8,144.0,148.4,150.9,152.8,157.5,160.6,162.5,169.5,173.9,179.1,183.7,191.4,195.7,200.7,203.3,207.7,210.3,215.5" style="fill:rgb(43,130,177);font-family:MuseeBold;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">International Journal of Nanomedicine</text>
  <text svgx:width="0.66,0.58,0.58,0.27,0.27,0.43,0.58,0.28,0.51,0.59,0.58,0.45,0.28,0.78,0.59,0.45,0.55,0.28,0.27,0.58,0.28,0.41,0.58,0.27,0.43,0.28,0.27,0.59,0.58,0.45,0.58,0.53,0.27" y="664.3" x="67.5,75.4,82.4,89.3,92.5,95.8,100.9,107.9,111.2,117.0,124.2,131.2,136.5,139.9,149.0,156.1,161.5,168.1,171.5,174.7,181.7,185.0,189.9,196.9,200.2,205.3,208.6,211.9,219.0,226.0,231.4,238.4,244.7" style="fill:rgb(134,134,133);font-family:GillSansMT-Bold;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Publish your work in this journal</text>
  <text svgx:width="0.6,0.58,0.58,0.96,0.27,0.41,0.28,0.51,0.59,0.58,0.45,0.28,0.96,0.53,0.58,0.58,0.43,0.5,0.45,0.27,0.58,0.41,0.28,0.58,0.55,0.45,0.55,0.27" y="722.1" x="68.5,72.1,75.6,79.1,84.9,86.5,88.9,90.6,93.5,97.1,100.6,103.3,104.9,110.7,113.9,117.3,120.8,123.4,126.4,129.1,130.7,134.2,136.6,138.3,141.8,145.1,147.7,151.0" style="fill:rgb(134,134,133);font-family:GillSansMT-Bold;font-size:6.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Submit your manuscript here:</text>
  <text svgx:width="0.5,0.33,0.33,0.5,0.22,0.28,0.28,0.72,0.72,0.72,0.22,0.51,0.55,0.44,0.48,0.5,0.4,0.48,0.38,0.38,0.22,0.44,0.55,0.77,0.28,0.22,0.5,0.33,0.48,0.4,0.5,0.43,0.33,0.22,0.55,0.5,0.43,0.22,0.32,0.22,0.55,0.5,0.4,0.5,0.43,0.22,0.32,0.55,0.25,0.32,0.5,0.43,0.5,0.55,0.77,0.48,0.51,0.22,0.44,0.22,0.5,0.48,0.32,0.22,0.55,0.5,0.4,0.5,0.43" y="722.1" x="154.3,157.3,159.3,161.3,164.3,165.6,167.3,169.0,173.3,177.6,181.5,182.8,185.9,189.2,191.7,194.5,197.5,199.8,202.7,205.0,207.3,208.6,211.2,214.5,219.2,220.9,222.2,225.2,227.2,230.0,232.4,235.4,238.0,240.0,241.3,244.6,247.6,250.2,251.5,253.4,254.7,258.0,261.0,263.4,266.4,269.0,270.3,272.2,275.5,277.0,279.0,282.0,284.5,287.5,290.9,295.5,298.4,301.4,302.7,305.4,306.7,309.7,312.5,314.5,315.8,319.1,322.1,324.5,327.5" style="fill:rgb(134,134,133);font-family:GillSansMT;font-size:6.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">http://www.dovepress.com/international-journal-of-nanomedicine-journa</text>
  <text svgx:width="0.22" y="722.1" x="330.1" style="fill:rgb(134,134,133);font-family:GillSansMT;font-size:6.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">l</text>
  <text svgx:width="0.61,0.5,0.44,0.25,0.33,0.5,0.28,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.39,0.5,0.5,0.33,0.5,0.44,0.28,0.25,0.5,0.33,0.25,0.72,0.44,0.5,0.5,0.78,0.44,0.5,0.28,0.44,0.28,0.5,0.44,0.25,0.28,0.39,0.25,0.44,0.5,0.25,0.28,0.5,0.28,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.25,0.5,0.44,0.44,0.33,0.33" y="678.1" x="68.5,73.4,77.4,81.0,83.4,86.1,90.1,92.3,95.9,98.5,102.5,106.1,108.3,110.5,114.5,118.5,122.1,124.3,126.8,129.9,133.9,137.9,140.6,144.6,148.1,150.4,152.9,156.9,159.5,162.0,167.8,171.3,175.3,179.3,185.6,189.1,193.1,195.3,198.9,201.1,205.1,208.7,211.1,213.4,216.5,219.0,222.5,226.5,229.0,231.2,235.2,237.5,241.0,243.7,247.7,251.2,253.5,255.7,259.7,263.7,267.2,269.5,271.5,273.9,277.9,281.5,285.0,287.7" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">The International Journal of Nanomedicine is an international, peer-</text>
  <text svgx:width="0.33,0.44,0.5,0.28,0.44,0.72,0.44,0.5,0.25,0.55,0.28,0.5,0.5,0.33,0.5,0.44,0.28,0.25,0.55,0.33,0.5,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.5,0.5,0.28,0.44,0.44,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.25" y="686.1" x="68.5,71.3,75.1,79.2,81.6,85.3,91.3,95.0,99.2,101.2,102.3,104.7,108.9,113.1,115.9,120.1,123.8,126.2,128.2,129.4,132.2,136.4,140.1,144.2,147.5,149.9,154.1,158.3,160.3,161.4,165.6,169.8,171.8,172.9,175.3,179.5,183.2,185.2,186.4,190.1,194.3,198.4,200.8,203.2,206.9,210.7,213.0,215.4,219.6,223.8,225.8,226.9,231.1,233.9,235.9,237.1,241.3,245.0,249.2,253.3,255.7,259.4,263.2,267.3,271.5,275.7,278.1,282.2,286.4,290.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">reviewed journal focusing on the application of nanotechnology </text>
  <text svgx:width="0.28,0.5,0.25,0.55,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.28,0.44,0.39,0.25,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.44,0.5,0.28,0.28,0.44,0.39,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.5,0.44,0.33,0.5,0.25,0.55,0.39,0.5,0.39,0.28,0.44,0.78,0.39,0.25,0.55,0.28,0.5,0.33,0.5,0.5,0.5,0.5,0.5,0.5,0.28,0.25" y="694.1" x="68.5,70.8,74.8,76.8,77.9,81.9,84.2,87.8,91.9,95.9,99.9,103.1,105.4,107.7,111.3,114.4,116.5,118.5,119.5,121.8,125.8,129.4,132.1,135.7,139.8,143.4,147.4,149.7,152.0,155.6,158.7,160.8,162.8,163.8,167.4,171.5,175.5,177.5,178.6,182.6,185.3,189.4,193.4,195.4,196.5,200.5,204.1,206.4,208.7,212.7,216.3,219.0,223.1,225.1,226.1,229.3,233.3,236.5,238.8,242.4,248.6,251.8,253.8,254.9,257.1,261.2,263.9,267.9,272.0,276.0,280.1,284.1,288.2,290.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">in diagnostics, therapeutics, and drug delivery systems throughout </text>
  <text svgx:width="0.28,0.5,0.44,0.25,0.55,0.5,0.28,0.5,0.78,0.44,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.56,0.44,0.28,0.5,0.25,0.25,0.55,0.61,0.5,0.28,0.39,0.25,0.55,0.28,0.5,0.5,0.33,0.5,0.44,0.28,0.25,0.55,0.28,0.39,0.25,0.55,0.28,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.56,0.5,0.5,0.89,0.44,0.5,0.25,0.55,0.67,0.44,0.5,0.28,0.33,0.44,0.28,0.25,0.25" y="702.1" x="68.5,70.8,74.9,78.5,80.5,81.6,85.7,88.0,92.1,98.4,102.0,106.1,108.4,112.0,115.7,118.0,120.0,121.0,125.6,129.2,131.5,135.6,137.7,139.7,140.7,145.7,149.8,152.1,155.3,157.3,158.4,160.7,164.8,168.8,171.6,175.7,179.3,181.6,183.6,184.7,187.0,190.2,192.2,193.3,195.6,199.6,203.7,207.3,211.4,215.1,219.1,221.1,222.2,226.3,230.4,232.4,233.5,238.0,242.1,246.1,253.3,257.0,261.1,263.1,264.1,269.5,273.2,277.3,279.6,282.3,285.9,288.2,290.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">the biomedical field. This journal is indexed on PubMed Central, </text>
  <text svgx:width="0.25,0.89,0.44,0.5,0.61,0.28,0.5,0.44,0.25,0.25,0.55,0.67,0.72,0.56,0.25,0.25,0.55,0.56,0.44,0.28,0.56,0.44,0.44,0.33,0.44,0.5,0.76,0.25,0.25,0.55,0.67,0.5,0.33,0.33,0.44,0.5,0.28,0.25,0.55,0.67,0.5,0.5,0.28,0.44,0.5,0.28,0.39,0.76,0.28,0.67,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.89,0.44,0.5,0.28,0.44,0.28,0.5,0.44,0.25,0.25" y="710.1" x="68.5,68.5,75.6,79.2,83.2,88.1,90.3,94.3,97.8,99.8,101.8,102.7,108.0,113.8,118.2,120.2,122.2,123.1,127.5,131.1,133.3,137.7,141.3,144.8,147.5,151.1,155.1,161.1,163.1,165.1,166.0,171.3,175.3,178.0,180.6,184.2,188.2,190.4,192.4,193.2,198.6,202.6,206.6,208.8,212.4,216.4,218.6,221.7,227.8,230.0,235.3,237.6,239.8,243.8,246.0,249.6,253.1,255.3,257.3,258.2,265.3,268.8,272.8,275.1,278.6,280.8,284.8,288.4,290.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, </text>
  <text svgx:width="0.39,0.5,0.5,0.33,0.5,0.44,0.28,0.25,0.55,0.67,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.67,0.44,0.5,0.5,0.33,0.28,0.39,0.28,0.56,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.55,0.61,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.61,0.89,0.67,0.44,0.39,0.44,0.25,0.25,0.55,0.56,0.44,0.5,0.5,0.5,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25" y="678.1" x="304.6,307.7,311.7,315.7,318.4,322.4,325.9,328.2,330.2,331.1,336.4,338.6,340.8,344.4,346.6,348.8,352.8,356.8,358.8,359.8,365.1,368.6,372.6,376.6,379.3,381.5,384.6,386.9,391.3,394.9,397.1,400.6,404.6,408.2,411.8,413.8,414.7,419.6,423.6,425.8,428.0,430.2,434.2,438.2,440.2,442.2,443.1,448.0,455.1,460.5,464.0,467.1,470.7,472.7,474.7,475.6,480.0,483.6,487.6,491.6,495.6,498.7,500.7,501.6,505.2,509.2,513.2,515.2,516.1,518.3,522.3,525.9" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Journal Citation Reports/Science Edition, EMBase, Scopus and the </text>
  <text svgx:width="0.61,0.28,0.39,0.44,0.5,0.28,0.44,0.33,0.25,0.67,0.28,0.5,0.28,0.28,0.5,0.5,0.33,0.44,0.5,0.5,0.28,0.44,0.25,0.5,0.44,0.28,0.44,0.5,0.44,0.39,0.44,0.39,0.25,0.25,0.61,0.5,0.44,0.25,0.78,0.44,0.5,0.5,0.39,0.44,0.33,0.28,0.5,0.28,0.25,0.78,0.44,0.5,0.44,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.39,0.5,0.39,0.28,0.44,0.78,0.25" y="686.1" x="304.6,309.5,311.7,314.8,318.3,322.3,324.5,328.0,330.6,332.1,337.4,339.6,343.6,345.8,348.0,352.0,355.9,358.6,362.1,366.1,370.1,372.3,375.8,377.3,381.2,384.8,387.0,390.5,394.5,398.0,401.1,404.6,407.7,409.7,411.1,416.0,420.0,423.5,425.0,431.2,434.7,438.7,442.7,445.8,449.3,451.9,454.1,458.1,460.3,461.8,468.0,471.5,475.5,479.0,483.0,486.5,492.7,496.2,500.2,502.4,503.9,507.0,510.9,514.0,516.2,519.8,526.0" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Elsevier Bibliographic databases. The manuscript management system </text>
  <text svgx:width="0.28,0.39,0.25,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.44,0.28,0.5,0.25,0.5,0.5,0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.39,0.25,0.44,0.25,0.5,0.44,0.33,0.5,0.25,0.5,0.5,0.28,0.44,0.5,0.25,0.44,0.5,0.5,0.25,0.33,0.44,0.28,0.33,0.25,0.5,0.44,0.44,0.33,0.33,0.33,0.44,0.5,0.28,0.44,0.72,0.25" y="694.1" x="304.6,306.8,309.9,312.5,316.1,320.1,326.3,330.3,332.5,336.1,338.3,341.8,344.1,348.1,350.6,354.6,358.6,360.9,363.1,367.1,370.6,373.2,376.8,380.8,384.8,387.3,389.6,393.6,397.1,399.3,403.3,407.3,410.9,414.0,416.6,420.1,422.7,426.7,430.3,432.9,436.9,439.5,443.5,447.5,449.7,453.3,457.3,459.9,463.4,467.4,471.4,474.0,476.6,480.2,482.4,485.1,487.7,491.7,495.2,498.8,501.4,504.1,506.8,510.3,514.3,516.5,520.1,525.9" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">is completely online and includes a very quick and fair peer-review </text>
  <text svgx:width="0.39,0.5,0.39,0.28,0.44,0.78,0.25,0.25,0.55,0.72,0.5,0.28,0.44,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.28,0.28,0.25,0.55,0.44,0.44,0.39,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.39,0.44,0.25,0.25,0.55,0.72,0.28,0.39,0.28,0.28,0.25" y="702.1" x="304.6,307.8,311.8,315.0,317.2,320.8,327.1,329.2,331.2,332.2,338.0,342.1,344.4,348.0,352.0,354.0,355.0,357.3,360.5,362.5,363.5,367.1,369.4,371.7,373.7,374.7,378.3,381.9,385.1,389.1,391.1,392.2,394.4,398.5,400.5,401.5,405.6,408.8,412.4,414.4,416.4,417.4,423.3,425.5,428.7,431.0,433.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">system, which is all easy to use. Visit </text>
  <text svgx:width="0.5,0.28,0.28,0.5,0.28,0.28,0.28,0.72,0.72,0.72,0.25,0.5,0.5,0.5,0.44,0.5,0.33,0.44,0.39,0.39,0.25,0.44,0.5,0.78,0.28" y="702.1" x="436.3,440.3,442.6,444.9,448.9,451.2,453.5,455.7,461.6,467.4,473.2,475.2,479.3,483.3,487.4,491.0,495.0,497.8,501.4,504.5,507.7,509.7,513.3,517.4,523.6" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">http://www.dovepress.com/</text>
  <text svgx:width="0.28,0.44,0.39,0.28,0.28,0.78,0.5,0.5,0.28,0.44,0.28,0.39,0.25,0.5,0.5" y="710.1" x="304.6,306.8,310.4,313.5,315.7,317.9,324.2,328.2,332.2,334.4,337.9,340.2,343.3,345.3,349.3" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">testimonials.ph</text>
  <text svgx:width="0.5" y="710.1" x="353.3" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">p</text>
  <text svgx:width="0.25,0.28,0.5,0.25,0.33,0.44,0.44,0.5,0.25,0.33,0.44,0.44,0.28,0.25,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.5,0.5,0.28,0.28,0.39,0.5,0.44,0.5,0.25,0.44,0.5,0.28,0.5,0.5,0.33,0.39,0.25" y="710.1" x="357.3,359.3,361.5,365.5,367.5,370.2,373.7,377.3,381.3,383.3,385.9,389.5,393.0,395.3,397.3,401.3,405.3,409.3,411.5,415.0,418.1,420.1,422.8,425.5,429.5,435.7,437.7,441.7,445.7,449.7,451.9,454.1,457.3,461.3,464.8,468.8,470.8,474.4,478.4,480.6,484.6,488.6,491.2,494.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> to read real quotes from published authors.</text>
  <text svgx:width="0.25,0.5,0.33,0.48,0.4,0.5,0.43,0.33,0.22,0.55,0.5,0.43,0.22,0.28,0.25,0.55,0.5,0.4,0.5,0.43,0.22,0.28,0.55,0.25,0.28,0.78,0.43,0.5,0.55,0.77,0.48,0.51,0.22,0.44,0.22,0.5,0.48,0.28,0.5,0.5,0.5,0.5,0.22,0.5,0.5" y="758.4" x="389.4,391.4,395.4,398.1,401.9,405.1,409.1,412.5,415.2,416.9,421.3,425.3,428.8,430.5,432.7,434.6,439.0,443.0,446.2,450.2,453.6,455.3,457.5,462.0,464.0,466.2,472.4,475.9,479.9,484.3,490.4,494.3,498.3,500.1,503.6,505.4,509.4,513.2,515.4,519.4,523.4,527.4,531.4,533.2,537.2" style="fill:rgb(23,22,21);font-family:GillSansMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">International Journal of Nanomedicine 2018:13</text>
  <text svgx:width="0.43,0.58,0.58,0.96,0.27,0.41,0.28,0.51,0.59,0.58,0.45,0.28,0.96,0.53,0.58,0.58,0.43,0.5,0.45,0.27,0.58,0.41,0.28" y="756.3" x="89.9,92.0,94.9,97.8,102.6,104.0,106.0,107.4,109.8,112.8,115.7,117.9,119.3,124.1,126.8,129.6,132.5,134.7,137.2,139.4,140.8,143.7,145.7" style="fill:rgb(134,134,133);font-family:GillSansMT-Bold;font-size:5.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">submit your manuscript </text>
  <text svgx:width="0.26,0.28" y="756.3" x="147.1,148.4" style="fill:rgb(194,194,194);font-family:GillSansMT;font-size:5.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">| </text>
  <text svgx:width="0.72,0.72,0.72,0.22,0.51,0.55,0.44,0.48,0.5,0.4,0.48,0.38,0.38,0.22,0.44,0.55" y="756.3" x="149.8,153.4,157.0,160.3,161.4,163.9,166.6,168.7,171.1,173.6,175.5,177.9,179.8,181.7,182.8,185.0" style="fill:rgb(194,194,194);font-family:GillSansMT;font-size:5.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">www.dovepress.co</text>
  <text svgx:width="0.77" y="756.3" x="187.8" style="fill:rgb(194,194,194);font-family:GillSansMT;font-size:5.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">m</text>
  <text svgx:width="0.85,0.58,0.56,0.54" y="766.6" x="89.9,94.9,98.4,101.8" style="fill:rgb(43,130,177);font-family:MuseeBold;font-size:6.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Dove</text>
  <text svgx:width="0.64,0.47,0.54,0.47,0.47,0.24" y="766.6" x="105.0,108.8,111.7,114.9,117.7,120.6" style="fill:rgb(194,194,194);font-family:MuseeBold;font-size:6.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">press </text>
  <text svgx:width="0.85,0.58,0.56,0.54" y="36.2" x="500.2,507.0,511.6,516.1" style="fill:rgb(43,130,177);font-family:MuseeBold;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Dove</text>
  <text svgx:width="0.64,0.47,0.54,0.47,0.47" y="36.2" x="520.4,525.5,529.3,533.6,537.4" style="fill:rgb(194,194,194);font-family:MuseeBold;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">press</text>
  <text svgx:width="0.85,0.58,0.56,0.54" y="650.3" x="464.6,474.7,481.7,488.4" style="fill:rgb(43,130,177);font-family:MuseeBold;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Dove</text>
  <text svgx:width="0.64,0.47,0.54,0.47" y="650.3" x="494.9,502.6,508.2,514.7" style="fill:rgb(194,194,194);font-family:MuseeBold;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">pres</text>
  <text svgx:width="0.47" y="650.3" x="520.3" style="fill:rgb(194,194,194);font-family:MuseeBold;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">s</text>
  <text svgx:width="0.55,0.55,0.55" y="759.8" x="53.9,59.4,64.9" style="fill:rgb(23,22,21);font-family:GillSansMT-Bold;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">186</text>
  <text svgx:width="0.46,0.43,0.5,0.55,0.4,0.22,0.33,0.55,0.28,0.48,0.33,0.28,0.43,0.22" y="36.2" x="53.9,57.5,60.9,64.9,69.3,72.4,74.2,76.9,81.3,83.5,87.3,90.0,92.2,95.6" style="fill:rgb(23,22,21);font-family:GillSansMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">saporito et al</text>
  <text svgx:width="0.25,0.55,0.5,0.25,0.25,0.55,0.72,0.44,0.33,0.5,0.5,0.44,0.33,0.25,0.56,0.61,0.25,0.25,0.72,0.28,0.28,0.28,0.28,0.39,0.25,0.56,0.61,0.25,0.25,0.72,0.44,0.28,0.28,0.78,0.44,0.5,0.5,0.25,0.72,0.25,0.25,0.56,0.44,0.5,0.33,0.44,0.25,0.39,0.72,0.25,0.25,0.72,0.33,0.28,0.44,0.44,0.25,0.61,0.72,0.25,0.25,0.61,0.5,0.44,0.25,0.5,0.44,0.5,0.33,0.5" y="60.1" x="53.9,55.9,57.9,61.9,63.9,65.9,67.9,73.6,77.2,79.8,83.8,87.8,91.4,94.1,96.2,100.7,105.5,107.5,109.7,115.5,117.7,119.9,122.1,124.4,127.5,129.6,134.1,139.0,141.0,143.1,148.9,152.5,154.7,156.9,163.1,166.7,170.7,174.7,176.8,182.6,184.6,186.8,191.2,194.8,198.8,201.4,205.0,207.1,210.2,216.0,218.0,220.2,225.9,228.6,230.8,234.4,237.9,240.1,245.0,250.7,252.7,254.9,259.8,263.8,267.3,269.5,273.5,277.0,281.0,283.7" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 4. Gardner SE, Hillis SL, Heilmann K, Segre JA, Grice EA. The neuro</text>
  <text svgx:width="0.33" y="60.1" x="287.7" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">-</text>
  <text svgx:width="0.5,0.44,0.28,0.5,0.28,0.44,0.25,0.5,0.28,0.44,0.5,0.44,0.28,0.28,0.44,0.25,0.33,0.5,0.5,0.28,0.25,0.5,0.28,0.44,0.44,0.33,0.25,0.78,0.28,0.44,0.33,0.5,0.5,0.28,0.5,0.78,0.44,0.25,0.28,0.39,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.33,0.44,0.44,0.28,0.5,0.33,0.39,0.25,0.25" y="70.1" x="67.9,71.8,75.3,77.5,81.5,83.7,87.2,88.6,92.6,94.8,98.3,102.2,105.7,107.9,110.1,113.6,115.1,117.7,121.7,125.6,127.8,129.3,133.2,135.4,138.9,142.4,145.1,146.5,152.7,154.9,158.4,161.0,165.0,168.9,171.1,175.1,181.3,184.8,186.2,188.4,191.5,192.9,196.5,199.5,202.6,206.6,210.1,212.3,215.8,218.0,221.5,225.4,226.9,232.6,234.8,237.0,240.9,242.4,245.9,248.1,250.3,254.2,256.4,259.9,263.5,265.6,267.1,269.7,273.2,276.7,278.9,282.9,285.5,288.6,290.6" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">pathic diabetic foot ulcer microbiome is associated with clinical factors. </text>
  <text svgx:width="0.72,0.28,0.5,0.5,0.44,0.28,0.44,0.39" y="80.1" x="67.9,73.6,75.9,79.9,83.9,87.4,89.6,93.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Diabetes</text>
  <text svgx:width="0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.33,0.5,0.33,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="80.1" x="96.3,98.3,100.3,104.3,108.3,112.3,116.3,118.5,122.5,126.5,129.2,133.2,135.8,138.1,142.1,146.1,150.1,154.1,158.1,162.1,166.1" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. 2013;62(3):923–930.</text>
  <text svgx:width="0.25,0.55,0.5,0.25,0.25,0.55,0.67,0.5,0.72,0.28,0.44,0.33,0.25,0.56,0.72,0.25,0.25,0.72,0.5,0.44,0.33,0.5,0.44,0.5,0.25,0.67,0.33,0.25,0.25,0.72,0.33,0.78,0.39,0.28,0.33,0.5,0.5,0.5,0.25,0.72,0.72,0.25,0.25,0.94,0.5,0.5,0.5,0.5,0.25,0.78,0.28,0.44,0.33,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.39,0.39,0.5" y="90.1" x="53.9,55.9,57.9,61.9,63.9,65.9,67.9,73.1,77.0,82.7,84.8,88.2,90.8,92.1,96.5,102.2,104.1,105.4,111.1,115.0,118.4,121.0,124.9,128.3,132.2,133.6,138.8,141.4,143.3,144.6,150.3,152.9,159.0,162.0,164.1,166.7,170.6,174.5,178.4,179.7,185.4,191.1,193.0,194.3,201.8,205.7,209.6,213.5,217.4,218.7,224.8,227.0,230.4,233.0,236.9,240.8,242.9,246.8,248.9,252.8,256.7,260.6,261.9,265.4,269.3,273.2,274.5,278.0,281.0,284.0" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 5. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and asso</text>
  <text svgx:width="0.33" y="90.1" x="287.7" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">-</text>
  <text svgx:width="0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.44,0.5,0.5,0.33,0.5,0.44,0.44,0.5,0.44,0.39,0.25,0.28,0.5,0.25,0.72,0.5,0.5,0.5,0.5,0.25,0.78,0.44,0.5,0.44,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.25" y="100.1" x="67.9,71.4,73.6,77.2,79.4,83.0,87.0,89.3,92.8,96.8,100.8,103.5,107.5,111.0,114.6,118.6,122.1,125.3,127.6,129.8,133.8,136.1,141.9,145.9,149.9,153.9,157.9,160.2,166.4,170.0,174.0,177.5,181.5,185.1,191.3,194.9,198.9,201.1,203.1" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ciated approaches to wound management. </text>
  <text svgx:width="0.67,0.28,0.28,0.5,0.25,0.83,0.28,0.44,0.39,0.5,0.5,0.28,0.5,0.28,0.25,0.61,0.44,0.44" y="100.1" x="205.4,210.8,213.0,215.2,219.2,221.5,228.2,230.4,234.0,237.1,241.1,245.1,247.3,251.3,253.5,255.9,260.7,264.3" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Clin Microbiol Rev</text>
  <text svgx:width="0.25,0.25,0.5,0.5,0.5,0.5,0.28" y="100.1" x="267.9,269.9,272.2,276.2,280.2,284.2,288.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. 2001;</text>
  <text svgx:width="0.5,0.5,0.33,0.5,0.33,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="110.1" x="67.9,71.9,75.9,78.5,82.5,85.2,87.4,91.4,95.4,99.4,103.4,107.4,111.4,115.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">14(2):244–269.</text>
  <text svgx:width="0.25,0.55,0.5,0.25,0.25,0.55,0.39,0.44,0.5,0.33,0.5,0.78,0.28,0.25,0.89,0.72,0.89,0.25,0.25,0.61,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.56,0.56,0.25,0.25,0.67,0.44,0.39,0.33,0.28,0.25,0.56,0.89,0.89,0.25,0.25,0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.72,0.44,0.5,0.5,0.78,0.44,0.5,0.28,0.44,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.25" y="120.1" x="53.9,55.9,57.9,61.9,63.9,65.9,67.9,71.0,74.5,78.5,81.2,85.2,91.4,93.6,96.2,103.3,109.1,116.2,118.2,120.7,125.6,129.2,133.2,137.2,140.7,144.7,148.3,152.3,154.9,159.3,163.7,165.7,168.3,173.6,177.2,180.3,183.0,185.2,187.8,192.2,199.3,206.4,208.4,211.0,214.5,216.8,219.3,222.9,225.1,227.1,229.7,235.4,239.0,243.0,247.0,253.2,256.8,260.8,263.0,266.5,268.8,272.8,276.3,278.9,282.4,286.4,290.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 6. Jahromi MAM, Zangabad PS, Basri SMM, et al. Nanomedicine and </text>
  <text svgx:width="0.44,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.25,0.28,0.44,0.44,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.33,0.5,0.33,0.25,0.5,0.5,0.33,0.5,0.39,0.28,0.25,0.5,0.33,0.44,0.5,0.44,0.5,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.33,0.44,0.44,0.28,0.28,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25" y="130.1" x="67.9,71.4,75.4,79.4,83.0,87.0,90.5,94.1,98.1,100.0,102.2,105.8,109.3,113.3,117.3,121.3,123.6,127.6,131.6,133.8,137.3,140.5,142.4,145.1,149.1,151.7,153.7,157.7,161.7,164.4,168.4,171.5,173.7,175.7,179.7,182.3,185.9,189.9,193.4,197.4,199.7,201.9,205.9,209.9,211.8,214.1,218.1,220.7,224.3,227.8,230.1,232.3,236.3,240.3,242.2,245.8,249.8,253.8,255.8,258.4,262.0,265.5,267.7,270.0,272.2,274.4,278.0,280.2,282.4,286.4,290.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">advanced technologies for burns: preventing infection and facilitating </text>
  <text svgx:width="0.72,0.5,0.5,0.5,0.5,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.25" y="140.1" x="67.9,73.6,77.6,81.6,85.6,89.6,91.6,95.6,99.2,102.7,105.0,107.2,111.2,115.2,117.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">wound healing. </text>
  <text svgx:width="0.61,0.5,0.44,0.25,0.72,0.39,0.5,0.5,0.25,0.72,0.44,0.28,0.28,0.44,0.25,0.61,0.44,0.44" y="140.1" x="119.2,124.1,128.1,131.6,133.6,139.4,142.5,146.5,150.5,152.5,158.3,161.8,164.1,166.3,169.8,171.8,176.7,180.3" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Adv Drug Deliv Rev</text>
  <text svgx:width="0.25,0.25,0.61,0.5,0.5,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.72,0.5,0.5,0.25,0.5,0.25" y="140.1" x="183.8,185.8,187.8,192.7,196.7,200.7,204.7,206.7,210.7,214.7,218.7,222.7,224.7,230.5,234.5,238.5,240.5,244.5" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. Epub 2017 Aug 4.</text>
  <text svgx:width="0.25,0.55,0.5,0.25,0.25,0.55,0.56,0.5,0.44,0.28,0.25,0.89,0.25,0.25,0.61,0.5,0.28,0.28,0.5,0.33,0.28,0.44,0.28,0.28,0.25,0.28,0.5,0.44,0.25,0.5,0.28,0.5,0.5,0.44,0.28,0.25,0.44,0.5,0.44,0.28,0.28,0.44,0.5,0.5,0.44,0.25,0.5,0.5,0.39,0.44,0.5,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.78,0.5,0.28,0.28,0.28,0.33,0.44,0.39,0.28,0.39,0.28,0.44,0.5,0.28,0.25,0.28,0.5,0.28,0.44,0.33" y="150.1" x="53.9,55.9,57.9,61.9,63.9,65.9,67.9,72.3,76.2,79.7,81.9,83.3,90.4,92.3,93.8,98.6,102.6,104.8,106.9,110.9,113.5,115.7,119.2,121.4,123.5,125.0,127.2,131.1,134.6,136.1,140.0,142.2,146.1,150.1,153.6,155.8,157.2,160.7,164.7,168.2,170.4,172.5,176.0,180.0,183.9,187.5,188.9,192.9,196.8,199.9,203.4,207.3,208.8,212.5,216.5,217.9,220.1,224.1,227.6,229.0,235.2,239.1,241.3,243.5,245.7,248.3,251.8,254.8,257.0,260.1,262.3,265.8,269.7,271.9,273.3,275.5,279.5,281.6,285.1" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 7. Fuzi M. Editorial: the global challenge posed by the multiresistant inter</text>
  <text svgx:width="0.33" y="150.1" x="287.7" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">-</text>
  <text svgx:width="0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.44,0.28,0.5,0.5,0.44,0.39,0.25,0.5,0.33,0.25,0.5,0.44,0.44,0.28,0.44,0.33,0.28,0.44,0.28,0.25,0.5,0.44,0.28,0.5,0.5,0.5,0.44,0.5,0.39,0.25,0.25" y="160.1" x="67.9,71.9,75.4,77.6,79.9,83.9,87.9,91.4,93.6,95.6,99.2,101.4,105.4,109.4,113.0,116.1,118.1,122.1,124.7,126.7,130.7,134.3,137.8,140.1,143.6,146.3,148.5,152.1,154.3,156.3,160.3,163.8,166.1,170.1,174.1,178.1,181.6,185.6,188.7,190.7" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">national clones of bacterial pathogens. </text>
  <text svgx:width="0.61,0.39,0.5,0.5,0.28,0.25,0.83,0.28,0.44,0.39,0.5,0.5,0.28,0.5,0.28" y="160.1" x="192.7,197.6,200.7,204.7,208.7,210.9,212.9,219.6,221.8,225.4,228.5,232.5,236.5,238.7,242.7" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Front Microbiol</text>
  <text svgx:width="0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.5,0.25" y="160.1" x="244.9,246.9,248.9,252.9,256.9,260.9,264.9,267.2,271.2,273.4,277.4,281.4,285.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. 2017;8:817.</text>
  <text svgx:width="0.25,0.55,0.5,0.25,0.25,0.55,0.72,0.44,0.5,0.28,0.39,0.25,0.55,0.56,0.67,0.25,0.25,0.55,0.56,0.44,0.33,0.44,0.44,0.25,0.55,0.67,0.25,0.25,0.55,0.67,0.5,0.39,0.78,0.44,0.44,0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.5,0.33,0.44,0.28,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.39,0.28,0.25,0.55,0.72,0.5,0.5,0.5,0.5,0.25" y="170.1" x="53.9,55.9,57.9,61.9,63.9,65.9,67.9,73.7,77.4,81.5,83.9,87.1,89.1,90.3,94.8,100.3,102.4,104.4,105.5,110.1,113.8,116.6,120.2,123.9,125.9,127.0,132.5,134.6,136.6,137.8,143.2,147.3,150.6,156.9,160.6,164.3,167.9,172.1,174.4,176.8,180.4,184.1,186.5,189.7,191.7,192.8,196.5,200.6,204.7,206.7,207.9,212.0,215.7,218.0,222.1,224.9,228.6,230.9,232.9,234.1,238.2,241.0,245.1,249.2,253.4,257.0,259.4,262.6,265.0,267.0,268.1,274.0,278.1,282.2,286.4,290.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 8. Davis SC, Perez R. Cosmeceuticals and natural products: wound </text>
  <text svgx:width="0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.25" y="180.1" x="67.9,71.9,75.4,79.0,81.2,83.4,87.4,91.4,93.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">healing. </text>
  <text svgx:width="0.67,0.28,0.28,0.5,0.25,0.72,0.44,0.39,0.72,0.5,0.28,0.5,0.28" y="180.1" x="95.4,100.7,103.0,105.2,109.2,111.2,117.0,120.5,123.6,129.4,133.4,135.6,139.6" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Clin Dermatol</text>
  <text svgx:width="0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.33,0.5,0.33,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="180.1" x="141.8,143.8,145.8,149.8,153.8,157.8,161.8,164.1,168.1,172.1,174.7,178.7,181.4,183.6,187.6,191.6,195.6,199.6,203.6,207.6,211.6" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. 2009;27(5):502–506.</text>
  <text svgx:width="0.25,0.55,0.5,0.25,0.25,0.55,0.89,0.44,0.5,0.44,0.5,0.5,0.25,0.61,0.25,0.25,0.67,0.44,0.33,0.33,0.28,0.44,0.44,0.28,0.5,0.25,0.72,0.25,0.25,0.61,0.5,0.28,0.33,0.28,0.25,0.72,0.25,0.25,0.72,0.5,0.5,0.44,0.33,0.28,0.25,0.72,0.25,0.25,0.67,0.5,0.78,0.5,0.44,0.33,0.28,0.39,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.44,0.44,0.28,0.44,0.33,0.28,0.5,0.39,0.28,0.44,0.28,0.28,0.44,0.25" y="190.1" x="53.9,55.9,57.9,61.9,63.9,65.9,67.9,74.9,78.4,82.3,85.7,89.7,93.6,95.0,99.8,101.7,103.2,108.4,111.9,114.5,117.1,119.2,122.7,126.1,128.3,132.2,133.6,139.3,141.3,142.7,147.5,151.4,153.5,156.1,158.3,159.7,165.4,167.3,168.7,174.4,178.4,182.3,185.7,188.3,190.5,191.9,197.6,199.5,200.9,206.2,210.1,216.3,220.2,223.7,226.2,228.4,231.4,235.3,239.3,240.7,244.6,247.2,248.6,252.5,256.0,259.5,261.6,265.1,267.7,269.8,273.7,276.8,278.9,282.4,284.5,286.7,290.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 9. Mayaud L, Carricajo A, Zhiri A, Aubert G. Comparison of bacteriostatic </text>
  <text svgx:width="0.44,0.5,0.5,0.25,0.5,0.44,0.44,0.28,0.44,0.33,0.28,0.44,0.28,0.5,0.44,0.28,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.5,0.5,0.25,0.44,0.39,0.39,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.5,0.28,0.28,0.39,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.25,0.39,0.28,0.33,0.44,0.28,0.5,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.44,0.33,0.5,0.28,0.5,0.5,0.25" y="200.1" x="67.9,71.4,75.4,79.4,80.8,84.8,88.4,91.9,94.1,97.6,100.3,102.5,106.0,108.2,112.2,115.8,118.0,119.4,123.0,126.5,128.7,130.9,134.9,137.1,139.3,143.3,144.8,148.8,151.4,152.9,156.9,160.9,162.4,165.9,169.0,172.1,175.6,179.6,181.8,184.0,187.6,189.8,191.2,195.2,197.4,199.6,202.7,204.2,207.8,211.7,215.3,217.5,221.5,224.6,226.8,228.3,231.3,233.6,236.2,239.7,241.9,245.9,249.0,250.5,256.3,258.5,260.7,264.7,266.1,270.1,273.7,276.3,280.3,282.5,286.5,290.5" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">and bactericidal activity of 13 essential oils against strains with varying </text>
  <text svgx:width="0.39,0.44,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.28,0.28,0.5,0.28,0.5,0.28,0.28,0.44,0.39,0.25,0.25" y="210.1" x="67.9,71.0,74.5,78.5,81.6,83.9,86.1,88.3,92.3,94.5,96.7,100.7,102.7,105.0,109.0,111.0,114.5,118.5,120.7,123.0,127.0,129.2,133.2,135.4,137.6,141.2,144.3,146.3" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">sensitivity to antibiotics. </text>
  <text svgx:width="0.56,0.44,0.28,0.28,0.25,0.61,0.5,0.5,0.28,0.25,0.83,0.28,0.44,0.39,0.5,0.5,0.28,0.5,0.28" y="210.1" x="148.3,152.8,156.3,158.5,160.8,162.8,167.6,171.6,175.6,177.9,179.9,186.5,188.8,192.3,195.4,199.4,203.4,205.6,209.6" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Lett Appl Microbiol</text>
  <text svgx:width="0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.33,0.5,0.33,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="210.1" x="211.9,213.9,215.9,219.9,223.9,227.9,231.9,234.1,238.1,242.1,244.8,248.8,251.4,253.6,257.6,261.6,265.6,269.6,273.6,277.6,281.6" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. 2008;47(3):167–173.</text>
  <text svgx:width="0.25,0.5,0.5,0.25,0.25,0.55,0.72,0.28,0.28,0.33,0.72,0.5,0.44,0.44,0.44,0.5,0.5,0.25,0.72,0.25,0.25,0.61,0.5,0.33,0.44,0.5,0.25,0.56,0.25,0.25,0.67,0.44,0.5,0.5,0.44,0.28,0.28,0.25,0.89,0.25,0.25,0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.67,0.5,0.44,0.78,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.78,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25" y="220.1" x="53.9,53.9,57.9,61.9,63.9,65.9,67.9,73.6,75.9,78.1,80.7,86.5,90.5,94.1,97.6,101.2,105.2,109.2,111.0,116.8,118.8,120.7,125.5,129.5,132.2,135.8,139.8,141.6,146.1,148.1,149.9,155.3,158.8,162.8,166.8,170.4,172.6,174.8,176.7,183.8,185.8,187.6,191.2,193.4,195.3,198.8,201.0,203.0,204.9,210.2,214.2,217.8,224.0,226.2,229.8,233.3,235.6,237.4,241.0,245.0,251.2,255.2,259.2,262.3,264.5,266.8,269.0,273.0,277.0,278.8,282.4,286.4,290.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 10. Ait-Ouazzou A, Loran S, Bakkali M, et al. Chemical composition and </text>
  <text svgx:width="0.44,0.5,0.28,0.28,0.78,0.28,0.44,0.33,0.5,0.5,0.28,0.44,0.28,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.44,0.39,0.39,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.5,0.28,0.28,0.39,0.25,0.5,0.33,0.25,0.61,0.5,0.5,0.78,0.5,0.39,0.25,0.44,0.28,0.5,0.44,0.33,0.28,0.44,0.5,0.39,0.28,0.39,0.25,0.25,0.61,0.5,0.44,0.44,0.28,0.5,0.5,0.28,0.5,0.39,0.25" y="230.1" x="67.9,71.3,75.2,77.4,79.5,85.6,87.8,91.2,93.8,97.7,101.6,103.8,107.2,109.4,110.8,114.2,117.7,119.8,122.0,125.9,128.0,130.2,134.1,135.5,139.4,142.0,143.4,146.8,149.9,152.9,156.4,160.3,162.4,164.5,168.0,170.1,171.5,175.5,177.6,179.7,182.8,184.2,188.1,190.7,192.1,196.9,200.8,204.7,210.8,214.7,217.8,219.2,222.6,224.8,228.7,232.1,234.7,236.9,240.3,244.2,247.3,249.4,252.4,254.3,255.7,260.5,264.4,267.9,271.4,273.5,277.4,281.3,283.5,287.4,290.5" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">antimicrobial activity of essential oils of Thymus algeriensis, Eucalyptus </text>
  <text svgx:width="0.5,0.28,0.5,0.5,0.5,0.28,0.5,0.39,0.25,0.44,0.5,0.5,0.25,0.67,0.5,0.39,0.78,0.44,0.33,0.28,0.5,0.5,0.39,0.25,0.5,0.33,0.56,0.44,0.28,0.5,0.44,0.28,0.28,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.89,0.5,0.33,0.5,0.44,0.44,0.5,0.25,0.25" y="240.1" x="67.9,71.7,73.8,77.7,81.5,85.4,87.5,91.3,94.3,95.5,98.9,102.8,106.6,107.8,113.0,116.8,119.8,125.9,129.3,131.9,133.9,137.8,141.7,144.6,145.8,149.7,152.2,156.5,159.9,162.0,165.9,169.3,171.4,173.5,176.4,177.6,180.1,182.6,186.5,192.6,193.8,200.7,204.6,207.1,211.0,214.4,217.8,221.7,223.5" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">globulus and Rosmarinus officinalis from Morocco. </text>
  <text svgx:width="0.5,0.44,0.28,0.25,0.61,0.5,0.5,0.5,0.25,0.61,0.5,0.39,0.28,0.44" y="240.1" x="224.6,228.5,231.9,234.0,235.1,239.9,243.8,247.6,251.5,252.6,257.4,261.3,264.2,266.3" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Sci Food Agric</text>
  <text svgx:width="0.25,0.25,0.5,0.5,0.5,0.5,0.28" y="240.1" x="269.7,271.6,272.7,276.6,280.5,284.3,288.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. 2011;</text>
  <text svgx:width="0.5,0.5,0.33,0.5,0.5,0.33,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="250.1" x="67.9,71.9,75.9,78.5,82.5,86.5,89.2,91.4,95.4,99.4,103.4,107.4,111.4,115.4,119.4,123.4,127.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">91(14):2643–2651.</text>
  <text svgx:width="0.25,0.5,0.5,0.25,0.25,0.55,0.61,0.44,0.5,0.44,0.5,0.44,0.39,0.5,0.28,0.25,0.61,0.25,0.25,0.72,0.5,0.5,0.5,0.5,0.5,0.25,0.67,0.25,0.25,0.56,0.44,0.5,0.44,0.28,0.5,0.5,0.25,0.89,0.25,0.25,0.72,0.5,0.28,0.28,0.78,0.28,0.44,0.33,0.5,0.5,0.28,0.44,0.28,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.28,0.44,0.39,0.25,0.5,0.33,0.25,0.44,0.5,0.44,0.44" y="260.1" x="53.9,53.9,57.9,61.9,63.9,65.9,67.9,72.7,76.3,80.3,83.8,87.8,91.4,94.5,98.5,100.7,102.6,107.5,109.5,111.4,117.2,121.2,125.2,129.2,133.2,137.2,139.1,144.4,146.4,148.3,152.7,156.3,160.3,163.8,166.1,170.1,174.1,175.9,183.1,185.1,186.9,192.7,196.7,198.9,201.2,207.4,209.6,213.2,215.8,219.8,223.8,226.1,229.6,231.8,233.7,237.3,240.8,243.1,245.3,249.3,251.5,253.7,255.9,259.5,262.6,264.5,268.5,271.2,273.1,276.6,280.6,284.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 11. Takahashi T, Kokubo R, Sakaino M. Antimicrobial activities of euca</text>
  <text svgx:width="0.33" y="260.1" x="287.7" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">-</text>
  <text svgx:width="0.28,0.5,0.5,0.28,0.5,0.39,0.25,0.28,0.44,0.44,0.33,0.25,0.44,0.5,0.28,0.33,0.44,0.44,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.56,0.44,0.5,0.5,0.5,0.5,0.28,0.5,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.61,0.5,0.44,0.44,0.28,0.5,0.5,0.28,0.5,0.39,0.25,0.78,0.44,0.44,0.5,0.28,0.44,0.28,0.44,0.25,0.25" y="270.1" x="67.9,70.1,74.0,78.0,80.2,84.2,87.3,88.7,90.9,94.5,98.0,100.6,102.1,105.6,109.6,111.8,114.5,118.0,121.5,123.7,126.8,128.3,131.8,135.8,139.7,141.2,145.6,149.2,153.1,157.1,161.1,165.1,167.3,171.3,174.3,175.8,178.5,181.1,185.1,191.3,192.7,197.6,201.6,205.1,208.6,210.8,214.8,218.8,221.0,225.0,228.1,229.5,235.7,239.3,242.8,246.8,249.0,252.5,254.7,258.2,260.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">lyptus leaf extracts and flavonoids from Eucalyptus maculata. </text>
  <text svgx:width="0.56,0.44,0.28,0.28,0.25,0.61,0.5,0.5,0.28,0.25" y="270.1" x="261.6,266.0,269.5,271.7,273.9,275.4,280.2,284.2,288.2,290.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Lett Appl </text>
  <text svgx:width="0.83,0.28,0.44,0.39,0.5,0.5,0.28,0.5,0.28" y="280.1" x="67.9,74.5,76.7,80.3,83.4,87.4,91.4,93.6,97.6" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Microbiol</text>
  <text svgx:width="0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.33,0.5,0.33,0.28,0.5,0.5,0.5,0.5,0.5,0.25" y="280.1" x="99.9,101.9,103.9,107.9,111.9,115.9,119.9,122.1,126.1,130.1,132.7,136.7,139.4,141.6,145.6,149.6,153.6,157.6,161.6" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. 2004;39(1):60–64.</text>
  <text svgx:width="0.25,0.5,0.5,0.25,0.25,0.55,0.89,0.5,0.39,0.39,0.25,0.55,0.89,0.25,0.25,0.55,0.67,0.5,0.5,0.5,0.25,0.55,0.39,0.25,0.25,0.55,0.94,0.44,0.39,0.5,0.44,0.39,0.25,0.55,0.72,0.25,0.25,0.55,0.72,0.5,0.44,0.5,0.44,0.28,0.28,0.25,0.55,0.56,0.25,0.25,0.55,0.72,0.33,0.5,0.78,0.44,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.5,0.39,0.44,0.78,0.44,0.33,0.5,0.25,0.55,0.44,0.5,0.5,0.25" y="290.1" x="53.9,53.9,57.9,61.9,63.9,65.9,67.9,75.0,79.1,82.2,85.4,87.4,88.4,95.6,97.6,99.6,100.7,106.1,110.1,114.2,118.2,120.2,121.3,124.4,126.5,128.5,129.5,137.1,140.7,143.9,147.9,151.5,154.7,156.7,157.7,163.6,165.6,167.6,168.7,174.5,178.5,182.1,186.2,189.8,192.0,194.3,196.3,197.4,201.9,203.9,205.9,207.0,212.8,215.5,219.5,225.8,229.4,232.6,234.6,235.6,239.7,242.4,244.4,245.4,248.1,252.2,255.3,258.9,265.2,268.8,271.5,275.6,277.6,278.6,282.2,286.3,290.3" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 12. Moss M, Cook J, Wesnes K, Duckett P. Aromas of rosemary and </text>
  <text svgx:width="0.28,0.44,0.5,0.44,0.5,0.5,0.44,0.33,0.25,0.44,0.39,0.39,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.5,0.28,0.28,0.39,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.5,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.44,0.5,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.78,0.5,0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25" y="300.1" x="67.9,70.1,73.6,77.6,81.2,85.2,89.2,92.7,95.4,97.0,100.5,103.6,106.7,110.3,114.3,116.5,118.7,122.3,124.5,126.1,130.1,132.3,134.5,137.6,139.2,143.2,145.4,148.1,150.8,154.3,157.0,160.5,164.5,166.8,169.0,173.0,174.5,178.1,180.8,183.4,187.0,190.5,192.8,194.3,197.9,201.9,205.9,209.9,212.1,214.3,216.5,220.5,224.5,226.1,229.7,233.7,237.7,239.2,245.5,249.5,253.5,257.5,259.0,261.3,265.3,266.8,270.8,274.4,277.9,280.1,282.4,286.4,290.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">lavender essential oils differently affect cognition and mood in healthy </text>
  <text svgx:width="0.44,0.5,0.5,0.28,0.28,0.39,0.25,0.25" y="310.1" x="67.9,71.4,75.4,79.4,81.6,83.9,87.0,89.0" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">adults. </text>
  <text svgx:width="0.33,0.5,0.28,0.25,0.44,0.25,0.67,0.44,0.5,0.39,0.5,0.39,0.44,0.28" y="310.1" x="91.0,93.6,97.6,99.9,101.9,105.4,107.4,112.7,116.3,120.3,123.4,127.4,130.5,134.1" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Int J Neurosci</text>
  <text svgx:width="0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.33,0.28,0.5,0.5,0.5,0.5,0.5,0.25" y="310.1" x="136.3,138.3,140.3,144.3,148.3,152.3,156.3,158.5,162.5,166.5,170.5,173.2,177.2,179.8,182.1,186.1,190.1,194.1,198.1,202.1" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. 2003;113(1):15–38.</text>
  <text svgx:width="0.25,0.5,0.5,0.25,0.25,0.55,0.72,0.5,0.5,0.39,0.28,0.5,0.28,0.28,0.5,0.44,0.39,0.25,0.72,0.72,0.25,0.25,0.61,0.28,0.25,0.67,0.44,0.5,0.33,0.5,0.5,0.28,0.5,0.5,0.25,0.89,0.25,0.25,0.72,0.5,0.28,0.56,0.25,0.94,0.25,0.25,0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.67,0.5,0.44,0.78,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.78,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.5,0.25" y="320.1" x="53.9,53.9,57.9,61.9,63.9,65.9,67.9,73.6,77.5,81.5,84.5,86.7,90.6,92.8,95.0,98.9,102.4,105.5,106.9,112.6,118.3,120.3,121.7,126.6,128.7,130.2,135.4,138.8,142.8,145.4,149.3,153.3,155.4,159.4,163.3,164.8,171.8,173.8,175.2,180.9,184.9,187.0,191.4,192.9,200.4,202.3,203.7,207.2,209.4,210.8,214.3,216.5,218.5,219.9,225.2,229.1,232.6,238.8,240.9,244.4,247.9,250.1,251.5,255.0,259.0,265.2,269.1,273.0,276.1,278.3,280.4,282.6,286.5,290.5" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 13. Apostolides NA, El Beyrouthy M, Dhifi W, et al. Chemical composition </text>
  <text svgx:width="0.5,0.33,0.25,0.44,0.44,0.33,0.28,0.44,0.28,0.25,0.5,0.44,0.33,0.28,0.39,0.25,0.5,0.33,0.25,0.67,0.5,0.39,0.78,0.44,0.33,0.28,0.5,0.5,0.39,0.25,0.5,0.33,0.56,0.44,0.28,0.5,0.44,0.28,0.28,0.39,0.25,0.61,0.25,0.25,0.61,0.39,0.39,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.5,0.28,0.28,0.25,0.5,0.33,0.5,0.72,0.28,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25" y="330.1" x="67.9,71.9,74.5,76.6,80.1,83.7,86.3,88.6,92.1,94.3,96.4,100.4,103.9,106.6,108.8,111.9,114.0,118.0,120.7,122.7,128.1,132.1,135.2,141.4,144.9,147.6,149.8,153.8,157.8,160.9,163.0,167.0,169.7,174.1,177.7,179.9,183.9,187.4,189.7,191.9,195.0,197.1,201.9,203.9,206.0,210.9,214.0,217.1,220.7,224.7,226.9,229.1,232.7,234.9,236.9,240.9,243.2,245.4,247.5,251.5,254.1,258.1,263.9,266.1,270.1,274.1,276.2,281.9,284.2,286.4,290.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">of aerial parts of Rosmarinus officinalis L. Essential oil growing wild </text>
  <text svgx:width="0.28,0.5,0.25,0.61,0.44,0.5,0.44,0.5,0.5,0.5,0.25,0.25" y="340.1" x="67.9,70.1,74.1,76.1,81.0,84.5,88.5,92.1,96.1,100.1,104.1,106.1" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">in Lebanon. </text>
  <text svgx:width="0.44,0.25,0.61,0.39,0.39,0.44,0.5,0.28,0.25,0.72,0.28,0.28,0.25,0.61,0.44,0.5,0.39,0.25,0.61,0.28" y="340.1" x="108.1,111.6,113.6,118.5,121.6,124.7,128.3,132.3,134.5,136.5,142.3,144.5,146.7,148.7,153.6,157.2,161.2,164.3,166.3,171.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">J Essent Oil Bear Pl</text>
  <text svgx:width="0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.33,0.5,0.33,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="340.1" x="173.4,175.4,177.4,181.4,185.4,189.4,193.4,195.6,199.6,203.6,206.3,210.3,212.9,215.2,219.2,223.2,227.2,231.2,235.2,239.2,243.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. 2013;16(2):274–282.</text>
  <text svgx:width="0.25,0.5,0.5,0.25,0.25,0.55,0.56,0.28,0.44,0.5,0.5,0.28,0.44,0.72,0.28,0.44,0.44,0.25,0.89,0.25,0.25,0.61,0.5,0.39,0.44,0.5,0.5,0.72,0.39,0.5,0.44,0.25,0.89,0.25,0.25,0.56,0.44,0.39,0.28,0.5,0.39,0.44,0.5,0.44,0.25,0.89,0.25,0.25,0.67,0.28,0.44,0.5,0.28,0.44,0.39,0.25,0.94,0.25,0.25,0.72,0.5,0.72,0.44,0.28,0.44,0.44,0.5,0.5,0.25,0.61,0.25,0.25" y="350.1" x="53.9,53.9,57.9,61.9,63.9,65.9,67.9,72.2,74.3,77.8,81.7,85.6,87.8,91.2,96.9,99.1,102.5,106.0,107.4,114.4,116.3,117.7,122.5,126.5,129.5,132.9,136.9,140.8,146.5,149.5,153.4,156.9,158.3,165.3,167.2,168.6,173.0,176.4,179.5,181.6,185.5,188.5,192.0,195.9,199.4,200.8,207.8,209.7,211.1,216.4,218.5,222.0,225.9,228.0,231.5,234.5,235.9,243.4,245.3,246.7,252.4,256.3,262.0,265.4,267.6,271.0,274.5,278.4,282.3,283.7,288.5,290.5" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 14. Sienkiewicz M, Lysakowska M, Pastuszka M, Bienias W, Kowalczyk E. </text>
  <text svgx:width="0.61,0.5,0.44,0.25,0.55,0.5,0.5,0.28,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.39,0.44,0.25,0.55,0.5,0.44,0.39,0.28,0.28,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.5,0.39,0.44,0.78,0.44,0.33,0.5,0.25,0.55,0.44,0.39,0.39,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.55,0.5,0.28,0.28,0.39,0.25,0.55,0.44,0.39,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25" y="360.1" x="67.9,72.8,76.9,80.5,82.5,83.6,87.7,91.7,94.0,97.6,101.7,104.0,106.3,109.9,112.2,114.2,115.3,119.4,122.1,124.1,125.2,129.3,132.4,136.1,138.1,139.1,143.2,146.8,150.0,152.3,154.6,156.6,157.7,161.3,165.4,169.4,171.4,172.5,175.3,179.3,182.5,186.1,192.4,196.1,198.8,202.9,204.9,205.9,209.6,212.7,215.9,219.5,223.6,225.9,228.2,231.8,234.1,236.1,237.2,241.3,243.6,245.9,249.1,251.1,252.1,255.7,258.9,260.9,262.0,265.6,268.4,271.1,274.7,278.3,280.6,282.9,287.0,290.6" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">The potential of use basil and rosemary essential oils as effective </text>
  <text svgx:width="0.44,0.5,0.28,0.28,0.5,0.44,0.44,0.28,0.44,0.33,0.28,0.44,0.28,0.25,0.44,0.5,0.44,0.5,0.28,0.39,0.25,0.25" y="370.1" x="67.9,71.4,75.4,77.6,79.9,83.9,87.4,91.0,93.2,96.7,99.4,101.6,105.2,107.4,109.4,112.9,116.9,120.5,124.5,126.7,129.8,131.8" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">antibacterial agents. </text>
  <text svgx:width="0.83,0.5,0.28,0.44,0.44,0.5,0.28,0.44,0.39" y="370.1" x="133.8,140.5,144.5,146.7,150.3,153.8,157.8,160.0,163.6" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Molecules</text>
  <text svgx:width="0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.33,0.5,0.33,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="370.1" x="166.7,168.7,170.7,174.7,178.7,182.7,186.7,188.9,192.9,196.9,199.6,203.6,206.3,208.5,212.5,216.5,220.5,224.5,228.5,232.5,236.5,240.5,244.5" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. 2013;18(8):9334–9351.</text>
  <text svgx:width="0.25,0.5,0.5,0.25,0.25,0.55,0.72,0.33,0.5,0.28,0.28,0.39,0.33,0.72,0.44,0.72,0.44,0.25,0.61,0.25,0.25,0.72,0.5,0.33,0.5,0.28,0.5,0.28,0.44,0.72,0.28,0.44,0.44,0.33,0.39,0.44,0.44,0.5,0.25,0.72,0.25,0.25,0.61,0.28,0.5,0.5,0.39,0.5,0.78,0.44,0.39,0.25,0.44,0.39,0.25,0.5,0.44,0.28,0.28,0.5,0.44,0.33,0.5,0.25,0.39,0.5,0.39,0.28,0.44,0.78,0.39,0.25" y="380.1" x="53.9,53.9,57.9,61.9,63.9,65.9,67.9,73.6,76.3,80.3,82.5,84.7,87.9,90.5,96.3,99.5,105.3,108.9,110.7,115.6,117.6,119.5,125.3,129.3,131.9,135.9,138.2,142.2,144.4,147.9,153.7,155.9,159.5,163.0,165.7,168.8,172.4,175.9,179.9,181.8,187.6,189.6,191.5,196.3,198.6,202.6,206.6,209.7,213.7,219.9,223.5,226.6,228.4,232.0,235.1,237.0,241.0,244.5,246.8,249.0,253.0,256.5,259.2,263.2,265.1,268.2,272.2,275.3,277.5,281.1,287.3,290.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 15. Drulis-Kawa Z, Dorotkiewicz-Jach A. Liposomes as delivery systems </text>
  <text svgx:width="0.33,0.5,0.33,0.25,0.44,0.5,0.28,0.28,0.5,0.28,0.5,0.28,0.28,0.44,0.39,0.25" y="390.1" x="67.9,70.5,74.5,77.2,79.2,82.7,86.7,89.0,91.2,95.2,97.4,101.4,103.6,105.9,109.4,112.5" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">for antibiotics.</text>
  <text svgx:width="0.25,0.33,0.5,0.28,0.25,0.44,0.25,0.61,0.5,0.5,0.39,0.72,0.5,0.44,0.44,0.5,0.28" y="390.1" x="114.5,116.5,119.2,123.2,125.4,127.4,131.0,133.0,137.8,141.8,145.8,149.0,154.7,158.7,162.3,165.8,169.8" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> Int J Pharmaceut</text>
  <text svgx:width="0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.33,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="390.1" x="172.1,174.1,176.1,180.1,184.1,188.1,192.1,194.3,198.3,202.3,206.3,208.9,212.9,215.6,217.8,221.8,225.8,229.8,233.8,237.8,241.8,245.8" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. 2010;387(1):187–198.</text>
  <text svgx:width="0.25,0.5,0.5,0.25,0.25,0.55,0.72,0.5,0.5,0.44,0.44,0.25,0.61,0.72,0.25,0.25,0.72,0.5,0.33,0.5,0.78,0.44,0.44,0.25,0.61,0.25,0.25,0.72,0.44,0.28,0.28,0.44,0.33,0.44,0.25,0.61,0.25,0.25,0.56,0.44,0.5,0.5,0.33,0.28,0.25,0.72,0.25,0.25,0.67,0.5,0.5,0.33,0.44,0.33,0.5,0.5,0.28,0.25,0.89,0.67,0.25,0.25,0.72,0.44,0.44,0.33,0.25,0.72,0.25,0.25" y="400.1" x="53.9,53.9,57.9,61.9,63.9,65.9,67.9,73.6,77.6,81.6,85.2,88.7,90.8,95.7,101.5,103.5,105.6,111.4,115.4,118.0,122.0,128.3,131.8,135.4,137.5,142.3,144.3,146.4,152.2,155.8,158.0,160.2,163.8,166.4,170.0,172.1,177.0,179.0,181.1,185.5,189.1,193.1,197.1,199.7,201.9,204.0,209.8,211.8,213.9,219.3,223.3,227.3,229.9,233.5,236.1,240.1,244.1,246.4,248.5,255.6,260.9,262.9,265.0,270.8,274.3,277.9,280.5,282.6,288.4,290.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 16. Gokce EH, Korkmaz E, Dellera E, Sandri G, Bonferoni MC, Ozer O. </text>
  <text svgx:width="0.67,0.44,0.39,0.5,0.44,0.33,0.44,0.28,0.33,0.5,0.28,0.25,0.28,0.5,0.44,0.5,0.44,0.5,0.25,0.39,0.5,0.28,0.28,0.5,0.25,0.28,0.28,0.5,0.28,0.5,0.25,0.5,0.44,0.5,0.5,0.5,0.44,0.33,0.28,0.28,0.44,0.28,0.44,0.39,0.25,0.5,0.44,0.33,0.39,0.5,0.39,0.25,0.5,0.44,0.5,0.5,0.39,0.28,0.33,0.5,0.44,0.28,0.5,0.33,0.44,0.5,0.25,0.28,0.28,0.5,0.28,0.5,0.25" y="410.1" x="67.9,73.2,76.7,79.8,83.8,87.3,89.9,93.5,95.7,98.3,102.3,104.5,105.9,108.1,112.1,115.6,119.6,123.1,127.1,128.6,131.7,135.7,137.9,140.1,144.0,145.5,147.7,149.9,153.9,156.1,160.1,161.5,165.5,169.0,173.0,177.0,181.0,184.5,187.1,189.3,191.5,195.1,197.3,200.8,203.9,205.3,209.3,212.9,215.5,218.6,222.6,225.6,227.1,231.1,234.6,238.6,242.6,245.7,247.9,250.5,254.5,258.0,260.2,264.2,266.8,270.3,274.3,275.8,278.0,280.2,284.2,286.4,290.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Resveratrol loaded solid lipid nanoparticles versus nanostructured lipid </text>
  <text svgx:width="0.44,0.44,0.33,0.33,0.28,0.44,0.33,0.39,0.28,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.44,0.5,0.28,0.25,0.55,0.5,0.5,0.28,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.5,0.44,0.33,0.78,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.25" y="420.1" x="67.9,71.4,75.0,77.6,80.3,82.5,86.1,88.7,91.8,94.1,96.1,96.9,100.5,104.5,108.0,110.3,114.3,117.8,120.0,122.3,126.3,130.3,132.3,133.1,137.1,139.8,141.8,142.7,146.2,150.2,152.5,154.7,158.7,162.7,164.9,168.9,172.5,176.5,178.7,180.7,181.6,185.6,189.6,191.8,195.3,199.3,201.6,203.8,207.3,209.6,211.6,212.5,215.1,219.1,221.8,223.8,224.7,228.7,232.2,234.9,241.1,244.7,246.9,248.9,249.8,253.3,257.3,261.3,263.5,265.8,269.3,272.9,275.1,277.3,281.3,285.3,288.4,290.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">carriers: evaluation of antioxidant potential for dermal applications. </text>
  <text svgx:width="0.33,0.5,0.28,0.25,0.44,0.25,0.67,0.5,0.5,0.5,0.72,0.44,0.5" y="430.1" x="67.9,70.5,74.5,76.7,78.7,82.3,84.3,89.6,93.6,97.6,101.6,107.4,111.0" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Int J Nanomed</text>
  <text svgx:width="0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="430.1" x="115.0,117.0,119.0,123.0,127.0,131.0,135.0,137.2,141.2,143.4,147.4,151.4,155.4,159.4,163.4,167.4,171.4,175.4,179.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. 2012;7:1841–1850.</text>
  <text svgx:width="0.25,0.5,0.5,0.25,0.25,0.55,0.72,0.5,0.5,0.44,0.44,0.25,0.61,0.72,0.25,0.25,0.72,0.5,0.33,0.5,0.78,0.44,0.44,0.25,0.61,0.25,0.25,0.61,0.5,0.5,0.44,0.44,0.5,0.33,0.61,0.44,0.5,0.33,0.28,0.5,0.44,0.33,0.5,0.28,0.25,0.56,0.25,0.25,0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.72,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.44,0.28" y="60.1" x="304.6,304.6,308.6,312.6,314.6,316.6,318.6,324.3,328.2,332.2,335.7,339.2,340.6,345.4,351.1,353.1,354.5,360.2,364.1,366.7,370.7,376.8,380.3,383.8,385.2,390.1,392.0,393.4,398.3,402.2,406.1,409.6,413.1,417.0,419.6,424.5,428.0,431.9,434.5,436.7,440.6,444.1,446.7,450.6,452.8,454.2,458.6,460.5,462.0,465.4,467.6,469.0,472.5,474.7,476.6,478.1,483.8,485.2,488.7,492.6,498.8,502.7,506.2,508.8,512.3,514.5,516.6,520.6,524.0,525.5,529.0,532.9,536.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 17. Gokce EH, Korkmaz E, Tuncay-Tanrıverdi S, et al. A comparative eval</text>
  <text svgx:width="0.33" y="60.1" x="538.5" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">-</text>
  <text svgx:width="0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.5,0.44,0.5,0.44,0.5,0.78,0.44,0.25,0.72,0.5,0.5,0.25,0.28,0.5,0.44,0.5,0.44,0.5,0.25,0.28,0.28,0.5,0.5,0.39,0.5,0.78,0.44,0.39,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.28,0.28,0.5,0.25,0.28,0.28,0.5,0.28,0.5,0.25,0.5,0.44,0.5,0.5,0.5,0.44,0.33,0.28,0.28,0.44,0.28,0.44,0.39,0.25" y="70.1" x="318.6,322.6,326.1,328.3,330.5,334.4,338.4,339.9,343.8,346.5,348.0,351.5,355.4,359.0,362.9,366.4,370.4,376.6,380.1,381.6,387.3,391.3,395.3,396.8,398.9,402.9,406.4,410.4,413.9,417.9,419.4,421.6,423.7,427.7,431.7,434.8,438.7,444.9,448.4,451.5,453.0,456.5,460.5,464.4,465.9,469.0,473.0,475.2,477.4,481.3,482.8,485.0,487.2,491.1,493.3,497.3,498.8,502.7,506.3,510.2,514.2,518.2,521.7,524.3,526.5,528.7,532.2,534.4,537.9,541.0" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">uation of coenzyme Q10 loaded liposomes and solid lipid nanoparticles </text>
  <text svgx:width="0.44,0.39,0.25,0.5,0.44,0.33,0.78,0.44,0.28,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.44,0.5,0.28,0.25,0.44,0.44,0.33,0.33,0.28,0.44,0.33,0.39,0.25,0.25" y="80.1" x="318.6,322.2,325.3,327.3,331.3,334.8,337.5,343.7,347.3,349.5,351.5,355.0,359.0,361.3,363.5,367.5,371.5,373.7,377.7,381.3,385.3,387.5,389.5,393.0,396.6,399.2,401.9,404.1,407.7,410.4,413.5,415.5" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">as dermal antioxidant carriers. </text>
  <text svgx:width="0.33,0.5,0.28,0.25,0.44,0.25,0.67,0.5,0.5,0.5,0.72,0.44,0.5" y="80.1" x="417.5,420.1,424.1,426.4,428.4,431.9,433.9,439.2,443.2,447.2,451.2,457.0,460.6" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Int J Nanomed</text>
  <text svgx:width="0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="80.1" x="464.6,466.6,468.6,472.6,476.6,480.6,484.6,486.8,490.8,493.0,497.0,501.0,505.0,509.0,513.0,517.0,521.0,525.0,529.0" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. 2012;7:5109–5117.</text>
  <text svgx:width="0.25,0.5,0.5,0.25,0.25,0.55,0.56,0.44,0.5,0.5,0.33,0.28,0.25,0.72,0.25,0.25,0.67,0.5,0.5,0.33,0.44,0.33,0.5,0.5,0.28,0.25,0.89,0.67,0.25,0.25,0.72,0.33,0.72,0.5,0.28,0.28,0.28,0.28,0.44,0.25,0.56,0.25,0.25,0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.94,0.5,0.5,0.5,0.5,0.25,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.39,0.25,0.5,0.44,0.39,0.44,0.5,0.25,0.5,0.5,0.25" y="90.1" x="304.6,304.6,308.6,312.6,314.6,316.6,318.6,323.0,326.6,330.6,334.6,337.3,339.5,341.0,346.8,348.8,350.3,355.7,359.7,363.7,366.3,369.9,372.5,376.5,380.5,382.8,384.3,391.4,396.7,398.7,400.3,406.0,408.7,414.5,418.5,420.7,422.9,425.2,427.4,430.9,432.5,436.9,438.9,440.4,444.0,446.2,447.7,451.3,453.5,455.5,457.0,464.6,468.6,472.6,476.6,480.6,482.1,486.1,488.8,492.3,495.4,498.6,500.8,504.8,508.8,511.9,513.4,517.4,521.0,524.1,527.6,531.6,533.2,537.2,541.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 18. Sandri G, Bonferoni MC, D’Autilia F, et al. Wound dressings based on </text>
  <text svgx:width="0.39,0.28,0.28,0.5,0.44,0.33,0.25,0.39,0.5,0.28,0.33,0.44,0.5,0.28,0.44,0.44,0.28,0.5,0.44,0.25,0.56,0.61,0.72,0.25,0.33,0.5,0.33,0.25,0.28,0.28,0.39,0.39,0.5,0.44,0.25,0.33,0.44,0.5,0.44,0.28,0.33,0.28,0.5,0.5,0.25,0.25" y="100.1" x="318.6,321.7,323.9,326.2,330.2,333.7,336.4,338.7,341.8,345.8,348.1,350.7,354.3,358.3,360.5,364.1,367.6,369.8,373.8,377.4,379.8,384.2,389.1,394.9,397.2,399.9,403.9,406.6,408.9,411.1,413.4,416.5,419.6,423.6,427.1,429.5,432.2,435.7,439.7,443.3,445.5,448.2,450.4,454.4,458.4,460.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">silver sulfadiazine SLN for tissue repairing. </text>
  <text svgx:width="0.61,0.5,0.39,0.25,0.44,0.25,0.61,0.5,0.5,0.39,0.72,0.25,0.61,0.28,0.5,0.5,0.5,0.5,0.39,0.72" y="100.1" x="462.7,467.6,471.6,474.7,477.1,480.7,483.0,487.9,491.9,495.9,499.0,504.8,507.1,512.0,514.3,518.3,522.3,526.3,530.3,533.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Eur J Pharm Biopharm</text>
  <text svgx:width="0.25" y="100.1" x="539.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.33,0.5,0.33,0.28,0.5,0.5,0.5,0.5,0.5,0.25" y="110.1" x="318.6,322.6,326.6,330.6,334.6,336.8,340.8,344.8,347.5,351.5,354.2,356.4,360.4,364.4,368.4,372.4,376.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2013;84(1):84–90.</text>
  <text svgx:width="0.25,0.5,0.5,0.25,0.25,0.55,0.56,0.44,0.5,0.44,0.39,0.25,0.55,0.89,0.25,0.25,0.55,0.56,0.44,0.5,0.5,0.33,0.28,0.25,0.55,0.72,0.25,0.25,0.55,0.67,0.5,0.5,0.33,0.44,0.33,0.5,0.5,0.28,0.25,0.55,0.89,0.67,0.25,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.55,0.89,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.39,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.5,0.44,0.5,0.28,0.5,0.5,0.33,0.25" y="120.1" x="304.6,304.6,308.6,312.6,314.6,316.6,318.6,323.0,326.6,330.6,334.2,337.3,339.3,340.3,347.4,349.4,351.4,352.4,356.8,360.4,364.4,368.4,371.0,373.3,375.3,376.3,382.0,384.0,386.0,387.0,392.4,396.4,400.4,403.0,406.6,409.3,413.3,417.3,419.5,421.5,422.5,429.6,434.9,436.9,438.9,439.9,443.5,445.7,447.7,448.7,452.3,454.5,456.5,458.5,459.5,466.6,470.6,474.1,478.1,481.7,485.7,489.7,493.2,496.4,498.6,502.6,506.1,508.1,509.1,513.1,516.7,520.7,524.2,528.2,530.5,534.5,538.5,541.1" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 19. Szucs M, Sandri G, Bonferoni MC, et al. Mucoadhesive behaviour </text>
  <text svgx:width="0.5,0.33,0.25,0.44,0.78,0.5,0.28,0.39,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.5,0.5,0.28,0.5,0.78,0.44,0.33,0.28,0.44,0.25,0.44,0.78,0.5,0.28,0.39,0.28,0.56,0.44,0.33,0.25,0.25" y="130.1" x="318.6,322.6,325.3,327.4,330.9,337.2,341.2,343.4,346.5,348.7,352.7,356.7,358.8,362.4,366.4,370.4,372.6,376.2,378.4,382.4,384.6,388.6,392.6,394.7,398.7,402.7,404.9,408.9,415.2,418.7,421.4,423.6,427.2,429.3,432.8,439.0,443.0,445.3,448.4,450.6,455.0,458.6,461.3,463.3" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">of emulsion containing polymeric emulsifier. </text>
  <text svgx:width="0.61,0.5,0.39,0.25,0.44,0.25,0.61,0.5,0.5,0.39,0.72,0.25,0.5,0.44,0.28" y="130.1" x="465.4,470.3,474.3,477.4,479.5,483.0,485.2,490.0,494.0,498.0,501.2,506.9,509.0,513.0,516.6" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Eur J Pharm Sci</text>
  <text svgx:width="0.25" y="130.1" x="518.8" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28" y="130.1" x="522.9,526.9,530.9,534.9,538.9" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2008;</text>
  <text svgx:width="0.5,0.5,0.33,0.5,0.33,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="140.1" x="318.6,322.6,326.6,329.3,333.3,335.9,338.2,342.2,346.2,350.2,354.2,358.2,362.2,366.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">34(4):226–235.</text>
  <text svgx:width="0.25,0.5,0.5,0.25,0.25,0.55,0.56,0.44,0.5,0.5,0.33,0.28,0.25,0.72,0.25,0.25,0.67,0.5,0.39,0.39,0.28,0.25,0.56,0.25,0.25,0.67,0.5,0.5,0.33,0.44,0.33,0.5,0.5,0.28,0.25,0.89,0.67,0.25,0.25,0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.67,0.5,0.44,0.44,0.44,0.28,0.25,0.5,0.44,0.5,0.44,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.44,0.5,0.44,0.44" y="150.1" x="304.6,304.6,308.6,312.6,314.6,316.6,318.6,323.0,326.6,330.6,334.6,337.3,339.5,341.7,347.5,349.5,351.7,357.0,361.0,364.1,367.3,369.5,371.7,376.1,378.1,380.4,385.7,389.7,393.7,396.4,399.9,402.6,406.6,410.6,412.8,415.0,422.1,427.5,429.5,431.7,435.2,437.5,439.7,443.2,445.4,447.4,449.7,455.0,459.0,462.6,466.1,469.7,471.9,474.1,478.1,481.6,485.6,489.2,491.4,494.1,497.6,499.9,502.1,506.1,510.1,512.3,515.9,519.9,523.9,527.4,531.4,535.0" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 20. Sandri G, Rossi S, Bonferoni MC, et al. Buccal penetration enhance</text>
  <text svgx:width="0.33" y="150.1" x="538.5" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">-</text>
  <text svgx:width="0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.5,0.5,0.44,0.33,0.28,0.28,0.44,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.33,0.28,0.33,0.28,0.78,0.44,0.28,0.5,0.5,0.28,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.39,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.56,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.44,0.28,0.44,0.33,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25" y="160.1" x="318.6,324.8,328.4,332.4,334.6,336.6,337.4,341.4,344.0,348.0,352.0,355.6,358.3,360.5,362.7,366.3,369.4,371.4,372.2,376.2,378.8,380.8,381.6,387.4,390.0,392.3,394.9,397.2,403.4,406.9,409.2,413.2,417.2,419.4,421.4,422.2,425.7,429.7,431.9,434.2,438.2,441.3,444.8,448.8,451.1,453.1,453.8,456.1,460.1,464.5,468.5,472.1,476.1,479.6,483.2,485.2,486.0,490.0,492.6,494.6,495.4,499.4,503.4,507.0,509.2,512.7,515.4,519.4,521.6,525.2,528.7,530.9,533.2,537.2,541.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ment properties of N-trimethyl chitosan: influence of quaternization </text>
  <text svgx:width="0.5,0.44,0.5,0.33,0.44,0.44,0.25,0.5,0.5,0.25,0.44,0.5,0.39,0.5,0.33,0.5,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.25,0.5,0.28,0.5,0.5,0.25,0.78,0.5,0.28,0.44,0.44,0.5,0.28,0.44,0.33,0.25,0.72,0.44,0.28,0.5,0.5,0.28,0.25,0.78,0.5,0.28,0.44,0.44,0.5,0.28,0.44,0.25,0.25" y="170.1" x="318.6,322.6,326.1,330.0,332.7,336.2,339.7,341.1,345.1,349.1,350.5,354.0,358.0,361.1,365.0,367.6,371.6,373.8,376.0,379.9,383.9,385.3,389.3,391.9,393.4,396.9,398.4,402.3,404.5,408.5,412.4,413.9,420.1,424.0,426.2,429.7,433.2,437.2,439.4,442.9,445.5,447.0,452.7,456.2,458.4,462.4,466.3,468.5,470.0,476.1,480.1,482.3,485.8,489.3,493.3,495.4,499.0,500.9" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">degree on absorption of a high molecular weight molecule. </text>
  <text svgx:width="0.33,0.5,0.28,0.25,0.44,0.25,0.61,0.5,0.5,0.39,0.72" y="170.1" x="502.4,505.0,509.0,511.1,512.6,516.1,517.6,522.4,526.4,530.3,533.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Int J Pharm</text>
  <text svgx:width="0.25,0.25" y="170.1" x="539.2,541.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. </text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.33,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="180.1" x="318.6,322.6,326.6,330.6,334.6,336.8,340.8,344.8,348.8,351.5,355.5,358.2,360.4,364.4,368.4,372.4,376.4,380.4,384.4,388.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2005;297(1):146–155.</text>
  <text svgx:width="0.25,0.5,0.5,0.25,0.25,0.55,0.56,0.44,0.5,0.5,0.33,0.28,0.25,0.72,0.25,0.25,0.67,0.5,0.5,0.33,0.44,0.33,0.5,0.5,0.28,0.25,0.89,0.67,0.25,0.25,0.56,0.44,0.33,0.33,0.44,0.33,0.28,0.25,0.56,0.25,0.25,0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.89,0.5,0.5,0.28,0.78,0.5,0.33,0.28,0.28,0.28,0.5,0.5,0.28,0.28,0.44,0.33,0.44,0.5,0.28,0.28,0.5,0.39,0.44,0.5,0.33" y="190.1" x="304.6,304.6,308.6,312.6,314.6,316.6,318.6,323.0,326.6,330.6,334.6,337.3,339.5,342.0,347.8,349.8,352.4,357.7,361.7,365.7,368.4,371.9,374.6,378.6,382.6,384.8,387.3,394.4,399.8,401.8,404.3,408.8,412.3,415.0,417.7,421.2,423.9,426.1,428.6,433.1,435.1,437.6,441.2,443.4,446.0,449.5,451.7,453.7,456.3,463.4,467.4,471.4,473.6,479.8,483.8,486.5,488.7,490.9,493.2,497.2,501.2,503.4,505.6,509.2,511.8,515.4,519.4,521.6,523.8,527.8,530.9,534.5,538.5" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 21. Sandri G, Bonferoni MC, Ferrari F, et al. Montmorillonite-chitosan-</text>
  <text svgx:width="0.39,0.28,0.28,0.5,0.44,0.33,0.25,0.39,0.5,0.28,0.33,0.44,0.5,0.28,0.44,0.44,0.28,0.5,0.44,0.25,0.5,0.44,0.5,0.5,0.44,0.5,0.78,0.5,0.5,0.39,0.28,0.28,0.44,0.39,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.44,0.5,0.33,0.5,0.5,0.28,0.44,0.25,0.39,0.5,0.28,0.5,0.25" y="200.1" x="318.6,321.7,323.9,326.0,330.0,333.5,336.1,337.6,340.7,344.6,346.8,349.4,353.0,356.9,359.1,362.6,366.1,368.3,372.3,375.8,377.2,381.2,384.7,388.7,392.6,396.1,400.1,406.3,410.2,414.2,417.3,419.5,421.6,425.2,428.2,429.7,432.3,436.3,438.9,440.4,442.6,446.5,450.5,452.7,456.2,459.7,461.9,463.3,465.5,468.1,471.6,475.2,477.3,483.5,487.0,491.0,493.2,494.6,498.6,501.2,502.7,506.2,510.2,512.8,516.8,520.7,522.9,526.4,527.9,530.9,534.9,537.1,541.1" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">silver sulfadiazine nanocomposites for topical treatment of chronic skin </text>
  <text svgx:width="0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.28,0.25,0.28,0.5,0.25,0.5,0.28,0.28,0.33,0.5,0.25,0.5,0.28,0.5,0.44,0.5,0.78,0.5,0.44,0.28,0.28,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.25,0.44,0.5,0.28,0.28,0.5,0.44,0.44,0.28,0.44,0.33,0.28,0.44,0.28,0.25,0.44,0.33,0.56,0.44,0.44,0.44,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.5,0.25,0.44,0.28,0.5,0.39,0.5,0.33,0.44,0.25" y="210.1" x="318.6,320.8,324.3,327.4,329.6,333.6,337.6,340.7,342.9,344.4,346.6,350.6,352.1,356.1,358.3,360.5,363.1,367.1,368.6,372.6,374.8,378.8,382.3,386.3,392.5,396.5,400.0,402.2,404.4,408.4,410.6,412.8,415.1,417.3,421.2,423.2,424.7,428.3,432.2,434.4,436.7,440.6,444.2,447.7,449.9,453.5,456.1,458.3,461.8,464.1,465.5,469.1,471.7,476.2,479.7,483.2,486.6,490.6,492.1,495.7,499.6,503.6,505.1,509.1,512.6,516.6,518.1,521.6,523.8,527.8,530.9,534.9,537.6,541.1" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">lesions: in vitro biocompatibility, antibacterial efficacy and gap closure </text>
  <text svgx:width="0.44,0.44,0.28,0.28,0.25,0.78,0.5,0.28,0.28,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.5,0.5,0.44,0.33,0.28,0.28,0.44,0.39,0.25,0.25" y="220.1" x="318.6,322.2,325.7,327.9,330.2,332.2,338.4,342.4,344.6,346.8,349.0,351.3,353.5,357.5,359.5,363.5,366.2,370.2,374.2,377.7,380.4,382.6,384.8,388.4,391.5,393.5" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">cell motility properties. </text>
  <text svgx:width="0.67,0.5,0.39,0.5,0.5,0.5,0.44,0.5,0.25,0.61,0.5,0.28,0.44,0.72" y="220.1" x="395.5,400.8,404.8,407.9,411.9,415.9,419.9,423.5,427.5,429.5,434.4,438.4,440.6,444.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Carbohyd Polym</text>
  <text svgx:width="0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="220.1" x="449.9,451.9,453.9,457.9,461.9,465.9,469.9,472.2,476.2,480.2,484.2,486.4,490.4,494.4,498.4,502.4,506.4,510.4,514.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. 2014;102:970–977.</text>
  <text svgx:width="0.25,0.5,0.5,0.25,0.25,0.55,0.56,0.44,0.5,0.5,0.33,0.28,0.25,0.55,0.72,0.25,0.25,0.55,0.67,0.5,0.5,0.33,0.44,0.33,0.5,0.5,0.28,0.25,0.55,0.89,0.67,0.25,0.25,0.55,0.67,0.5,0.39,0.39,0.28,0.25,0.55,0.56,0.25,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.55,0.56,0.28,0.44,0.28,0.44,0.28,0.44,0.28,0.25,0.55,0.28,0.5,0.39,0.44,0.28,0.44,0.25,0.55,0.44,0.78,0.5,0.44,0.5,0.5,0.44,0.5,0.25" y="230.1" x="304.6,304.6,308.6,312.6,314.6,316.6,318.6,323.1,326.7,330.8,334.8,337.5,339.8,341.8,342.9,348.7,350.8,352.8,353.8,359.2,363.3,367.3,370.0,373.7,376.4,380.4,384.5,386.8,388.8,389.8,397.0,402.4,404.4,406.4,407.5,412.9,416.9,420.1,423.3,425.6,427.6,428.6,433.1,435.2,437.2,438.2,441.8,444.1,446.1,447.2,450.8,453.1,455.1,457.1,458.2,462.7,465.0,468.6,470.8,474.5,476.7,480.3,482.6,484.6,485.7,488.0,492.0,495.2,498.8,501.1,504.7,506.7,507.7,511.3,517.6,521.7,525.3,529.3,533.4,537.0,541.0" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 22. Sandri G, Bonferoni MC, Rossi S, et al. Platelet lysate embedded </text>
  <text svgx:width="0.39,0.44,0.44,0.33,0.33,0.5,0.28,0.5,0.39,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.39,0.5,0.28,0.5,0.25,0.55,0.33,0.44,0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25" y="240.1" x="318.6,321.7,325.3,328.8,331.5,334.1,338.1,340.4,344.4,347.5,349.5,350.4,353.1,357.1,359.7,361.7,362.7,365.8,369.8,372.0,376.0,378.0,379.0,381.6,385.2,389.2,392.7,396.7,400.3,402.9,406.5,408.7,410.9,414.9,418.9" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">scaffolds for skin regeneration.</text>
  <text svgx:width="0.25,0.55,0.61,0.44,0.5,0.44,0.39,0.28,0.25,0.55,0.72,0.5,0.28,0.5,0.25,0.55,0.72,0.39,0.5,0.5,0.25,0.55,0.72,0.44,0.28" y="240.1" x="420.9,422.9,423.9,428.8,432.3,436.3,439.9,443.0,445.2,447.2,448.1,453.9,457.9,460.1,464.1,466.1,467.1,472.8,476.0,480.0,484.0,486.0,486.9,492.7,496.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> Expert Opin Drug Del</text>
  <text svgx:width="0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.33,0.5,0.33,0.28" y="240.1" x="498.4,500.4,502.4,503.4,507.4,511.4,515.4,519.4,521.6,525.6,529.6,532.3,536.3,538.9" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. 2015;12(4):</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="250.1" x="318.6,322.6,326.6,330.6,334.6,338.6,342.6,346.6" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">525–554.</text>
  <text svgx:width="0.25,0.5,0.5,0.25,0.25,0.55,0.72,0.44,0.5,0.5,0.25,0.72,0.25,0.25,0.67,0.5,0.33,0.5,0.5,0.44,0.25,0.72,0.25,0.25,0.56,0.44,0.5,0.5,0.5,0.44,0.33,0.28,0.25,0.67,0.25,0.25,0.67,0.44,0.44,0.5,0.44,0.33,0.25,0.67,0.25,0.25,0.72,0.44,0.5,0.39,0.5,0.5,0.25,0.89,0.25,0.25,0.61,0.5,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.5,0.33,0.25" y="260.1" x="304.6,304.6,308.6,312.6,314.6,316.6,318.6,323.3,326.8,330.8,334.8,337.4,343.1,345.1,347.7,353.0,357.0,359.7,363.7,367.7,371.2,373.8,379.6,381.6,384.1,388.6,392.1,396.1,400.1,404.1,407.7,410.3,412.6,415.1,420.4,422.4,425.0,430.3,433.9,437.4,441.4,445.0,447.7,450.2,455.5,457.5,460.1,465.9,469.4,473.4,476.5,480.5,484.5,487.1,494.2,496.2,498.8,503.6,507.6,511.2,513.7,517.3,520.0,522.6,526.2,529.7,532.0,534.5,538.5,541.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 23. Yang Y, Corona A, Schubert B, Reeder R, Henson M. The effect of </text>
  <text svgx:width="0.5,0.28,0.28,0.25,0.55,0.28,0.5,0.5,0.44,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.39,0.28,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.5,0.5,0.39,0.28,0.33,0.5,0.44,0.28,0.5,0.33,0.44,0.5,0.25,0.55,0.28,0.28,0.5,0.28,0.5,0.25,0.55,0.44,0.44,0.33,0.33,0.28,0.44,0.33,0.39,0.25,0.25" y="270.1" x="318.6,322.6,324.8,327.0,329.0,329.7,332.0,336.0,340.0,343.5,345.5,346.2,350.2,354.2,356.2,356.9,359.1,363.1,366.6,368.6,369.3,372.9,376.9,380.9,383.5,387.1,391.1,394.6,396.9,399.1,403.1,407.1,409.1,409.8,412.9,415.1,418.7,422.7,424.9,427.1,429.3,431.6,435.6,437.6,438.2,442.2,444.9,446.9,447.6,451.6,455.1,459.1,463.1,466.2,468.5,471.1,475.1,478.7,480.9,484.9,487.6,491.1,495.1,497.1,497.8,500.0,502.2,506.2,508.5,512.5,514.5,515.2,518.7,522.3,524.9,527.6,529.8,533.4,536.0,539.1,541.1" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">oil type on the aggregation stability of nanostructured lipid carriers. </text>
  <text svgx:width="0.44,0.25,0.67,0.5,0.28,0.28,0.5,0.28,0.5,0.25,0.33,0.5,0.28,0.44,0.39,0.28,0.5,0.44,0.44,0.25,0.5,0.44,0.28" y="280.1" x="318.6,322.2,324.2,329.5,333.5,335.7,337.9,341.9,344.2,348.2,350.2,352.8,356.8,359.0,362.6,365.7,367.9,371.9,375.5,379.0,381.0,385.0,388.6" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">J Colloid Interface Sci</text>
  <text svgx:width="0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="280.1" x="390.8,392.8,394.8,398.8,402.8,406.8,410.8,413.0,417.0,421.0,425.0,427.3,431.3,435.3,439.3,443.3,447.3,451.3,455.3" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. 2014;418:261–272.</text>
  <text svgx:width="0.25,0.5,0.5,0.25,0.25,0.55,0.67,0.44,0.33,0.44,0.5,0.39,0.5,0.44,0.39,0.25,0.39,0.25,0.25,0.67,0.5,0.33,0.28,0.39,0.28,0.44,0.33,0.39,0.5,0.5,0.25,0.61,0.25,0.25,0.94,0.44,0.5,0.39,0.44,0.28,0.44,0.33,0.25,0.89,0.25,0.25,0.61,0.28,0.5,0.5,0.39,0.28,0.33,0.5,0.78,0.25,0.56,0.25,0.25,0.61,0.28,0.5,0.5,0.5,0.5,0.28,0.39,0.28,0.25,0.72,0.33,0.72,0.25,0.25" y="290.1" x="304.6,304.6,308.6,312.6,314.6,316.6,318.6,323.9,327.5,330.2,333.7,337.7,340.8,344.8,348.4,351.5,353.1,356.2,358.2,359.9,365.2,369.2,371.9,374.1,377.2,379.4,383.0,385.6,388.8,392.8,396.8,398.4,403.3,405.3,406.9,414.5,418.0,422.0,425.1,428.7,430.9,434.5,437.1,438.8,445.9,447.9,449.5,454.4,456.6,460.6,464.6,467.8,470.0,472.6,476.6,482.9,484.5,489.0,491.0,492.6,497.5,499.7,503.7,507.7,511.7,515.7,517.9,521.0,523.3,524.9,530.7,533.3,539.1,541.1" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 24. Barauskas J, Christerson L, Wadsater M, Lindstrom F, Lindqvist A-K, </text>
  <text svgx:width="0.61,0.28,0.5,0.44,0.33,0.5,0.25,0.55,0.56,0.25,0.25,0.55,0.67,0.28,0.5,0.44,0.5,0.5,0.44,0.39,0.28,0.5,0.44,0.25,0.55,0.28,0.28,0.5,0.28,0.5,0.25,0.55,0.44,0.5,0.78,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.5,0.39,0.28,0.25,0.55,0.39,0.44,0.28,0.33,0.33,0.44,0.39,0.39,0.44,0.78,0.5,0.28,0.5,0.25,0.55,0.39,0.28,0.33,0.5,0.44,0.28,0.5,0.33,0.44,0.39,0.25,0.25" y="300.1" x="318.6,323.5,325.7,329.7,333.3,336.0,340.0,342.0,343.0,347.4,349.4,351.4,352.5,357.8,360.0,364.0,367.6,371.6,375.6,379.2,382.3,384.5,388.5,392.1,394.1,395.1,397.3,399.6,403.6,405.8,409.8,411.8,412.8,416.4,420.4,426.6,430.6,434.6,437.8,440.0,442.2,444.5,448.5,452.5,455.6,457.8,459.8,460.8,464.0,467.5,469.7,472.4,475.1,478.6,481.8,484.9,488.4,494.7,498.7,500.9,504.9,506.9,507.9,511.1,513.3,516.0,520.0,523.5,525.8,529.8,532.4,536.0,539.1,541.1" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Tiberg F. Bioadhesive lipid compositions: self-assembly structures, </text>
  <text svgx:width="0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.78,0.44,0.5,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.5,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.25" y="310.1" x="318.6,321.2,325.2,329.2,332.7,334.9,337.1,341.1,345.1,348.6,350.8,353.0,355.2,359.2,360.7,364.2,368.2,372.1,373.6,379.8,383.3,387.3,389.5,393.0,396.6,398.8,400.3,403.8,407.8,411.7,413.9,416.1,419.7,423.2,425.4,427.6,431.6,435.5,438.6,440.6" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">functionality and medical applications. </text>
  <text svgx:width="0.83,0.5,0.28,0.25,0.61,0.5,0.5,0.39,0.72,0.44,0.44,0.5,0.28,0.28,0.44,0.39" y="310.1" x="442.1,448.8,452.7,454.9,456.4,461.3,465.3,469.2,472.3,478.1,481.6,485.1,489.1,491.3,493.5,497.0" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Mol Pharmceutics</text>
  <text svgx:width="0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.33,0.5,0.33,0.28" y="310.1" x="500.1,502.1,503.6,507.6,511.6,515.5,519.5,521.7,525.7,529.7,532.3,536.3,538.9" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. 2014;11(3):</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="320.1" x="318.6,322.6,326.6,330.6,334.6,338.6,342.6,346.6" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">895–903.</text>
  <text svgx:width="0.25,0.5,0.5,0.25,0.25,0.55,0.72,0.44,0.28,0.28,0.44,0.33,0.44,0.25,0.55,0.61,0.25,0.25,0.55,0.67,0.5,0.5,0.33,0.44,0.33,0.5,0.5,0.28,0.25,0.55,0.89,0.67,0.25,0.25,0.55,0.56,0.44,0.5,0.5,0.33,0.28,0.25,0.55,0.72,0.25,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.55,0.72,0.44,0.5,0.44,0.28,0.5,0.5,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.39,0.44,0.5,0.25" y="330.1" x="304.6,304.6,308.6,312.6,314.6,316.6,318.6,324.4,327.9,330.2,332.4,335.9,338.6,342.1,344.1,344.8,349.7,351.7,353.7,354.3,359.7,363.7,367.7,370.3,373.9,376.6,380.6,384.6,386.8,388.8,389.4,396.6,401.9,403.9,405.9,406.5,411.0,414.5,418.5,422.5,425.2,427.4,429.4,430.1,435.9,437.9,439.9,440.5,444.1,446.3,448.3,449.0,452.5,454.7,456.7,458.7,459.4,465.2,468.7,472.7,476.3,478.5,482.5,486.5,492.7,496.3,500.3,502.5,504.5,505.1,509.1,511.8,513.8,514.5,518.0,522.0,524.2,526.5,530.5,533.6,537.1,541.1" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 25. Dellera E, Bonferoni MC, Sandri G, et al. Development of chitosan </text>
  <text svgx:width="0.5,0.28,0.44,0.44,0.28,0.44,0.25,0.28,0.5,0.5,0.28,0.44,0.25,0.78,0.28,0.44,0.44,0.28,0.28,0.44,0.39,0.25,0.28,0.5,0.44,0.5,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.39,0.28,0.28,0.5,0.44,0.33,0.25,0.39,0.5,0.28,0.33,0.44,0.5,0.28,0.44,0.44,0.28,0.5,0.44,0.25,0.28,0.5,0.25,0.5,0.44,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25" y="340.1" x="318.6,322.6,324.8,328.4,331.9,334.2,337.7,340.2,342.4,346.4,350.4,352.6,356.2,358.6,364.8,367.1,370.6,374.2,376.4,378.6,382.2,385.3,387.8,390.0,394.0,397.5,401.5,405.1,409.1,411.5,417.3,419.5,421.8,425.8,428.2,431.3,433.6,435.8,439.8,443.3,446.0,448.5,451.6,455.6,457.8,460.5,464.0,468.0,470.2,473.8,477.3,479.6,483.6,487.1,489.6,491.8,495.8,498.3,502.3,505.8,508.3,511.8,514.9,518.0,522.0,525.6,527.8,531.4,533.6,537.1,541.1" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">oleate ionic micelles loaded with silver sulfadiazine to be associated </text>
  <text svgx:width="0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.28,0.44,0.28,0.44,0.28,0.44,0.28,0.25,0.55,0.28,0.5,0.39,0.44,0.28,0.44,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.5,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.25" y="350.1" x="318.6,324.4,326.6,328.8,332.9,334.9,335.9,339.9,342.1,345.7,347.9,351.5,353.7,357.2,359.5,361.5,362.5,364.7,368.7,371.8,375.4,377.6,381.2,383.2,384.2,386.9,390.9,393.6,395.6,396.6,400.1,404.1,408.1,410.4,412.6,416.2,419.7,422.0,424.2,428.2,432.2,434.2,435.2,437.4,441.5,443.5,444.5,450.2,454.3,458.3,462.3,466.3,468.3,469.3,473.3,476.9,480.4,482.6,484.9,488.9,492.9,494.9" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">with platelet lysate for application in wound healing. </text>
  <text svgx:width="0.61,0.5,0.39,0.25,0.55,0.44,0.25,0.55,0.61,0.5,0.5,0.39,0.72,0.25" y="350.1" x="497.8,502.7,506.7,509.8,511.8,512.8,516.4,518.4,519.4,524.3,528.3,532.3,535.4,541.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Eur J Pharm </text>
  <text svgx:width="0.61,0.28,0.5,0.5,0.5,0.5,0.39,0.72" y="360.1" x="318.6,323.5,325.7,329.7,333.7,337.7,341.7,344.8" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Biopharm</text>
  <text svgx:width="0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.33,0.5,0.33,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="360.1" x="350.6,352.6,354.6,358.6,362.6,366.6,370.6,372.8,376.8,380.8,383.5,387.5,390.2,392.4,396.4,400.4,404.4,408.4,412.4,416.4,420.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. 2014;88(3):643–650.</text>
  <text svgx:width="0.25,0.5,0.5,0.25,0.25,0.55,0.56,0.44,0.5,0.5,0.33,0.28,0.25,0.72,0.25,0.25,0.67,0.5,0.5,0.33,0.44,0.33,0.5,0.5,0.28,0.25,0.89,0.67,0.25,0.25,0.72,0.5,0.5,0.44,0.44,0.25,0.61,0.72,0.25,0.25,0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.67,0.5,0.28,0.28,0.5,0.39,0.44,0.5,0.33,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.56,0.61,0.72,0.28,0.25" y="370.1" x="304.6,304.6,308.6,312.6,314.6,316.6,318.6,323.0,326.6,330.6,334.6,337.3,339.5,341.6,347.3,349.3,351.4,356.7,360.7,364.7,367.4,370.9,373.6,377.6,381.6,383.8,385.9,393.0,398.3,400.3,402.4,408.2,412.2,416.2,419.7,423.3,425.4,430.2,436.0,438.0,440.1,443.6,445.9,447.9,451.5,453.7,455.7,457.8,463.1,467.1,469.3,471.5,475.5,478.7,482.2,486.2,488.9,492.4,495.5,498.6,502.6,506.2,508.4,512.0,514.2,517.8,521.8,523.8,528.3,533.2,538.9,541.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 26. Sandri G, Bonferoni MC, Gökçe EH, et al. Chitosan-associated SLN: </text>
  <text svgx:width="0.28,0.5,0.25,0.5,0.28,0.28,0.33,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.25,0.5,0.28,0.5,0.5,0.25,0.44,0.5,0.44,0.33,0.44,0.44,0.28,0.44,0.33,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.5,0.5,0.33,0.28,0.5,0.44,0.25,0.72,0.25,0.28,0.5,0.44,0.5,0.44,0.5,0.25,0.5,0.5,0.5,0.28,0.5,0.44,0.28" y="380.1" x="318.6,320.8,324.8,326.4,330.4,332.6,334.8,337.5,341.5,343.1,346.6,350.6,354.6,356.2,359.7,363.7,365.3,369.3,371.5,375.5,379.5,381.1,384.6,388.6,392.2,394.8,398.4,401.9,404.2,407.7,410.4,412.6,416.2,419.7,421.9,424.2,428.2,432.2,433.7,437.7,440.4,441.9,445.4,449.4,452.9,455.1,459.1,462.3,466.3,470.3,472.9,475.1,479.1,482.7,484.3,490.0,491.6,493.8,497.8,501.4,505.4,508.9,512.9,514.5,518.5,522.5,526.5,528.7,532.7,536.3" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">in vitro and ex vivo characterization of cyclosporine A loaded ophthal</text>
  <text svgx:width="0.33" y="380.1" x="538.5" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">-</text>
  <text svgx:width="0.78,0.28,0.44,0.25,0.39,0.5,0.39,0.28,0.44,0.78,0.39,0.25,0.25" y="390.1" x="318.6,324.8,327.0,330.6,332.6,335.7,339.7,342.8,345.0,348.6,354.8,357.9,359.9" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">mic systems. </text>
  <text svgx:width="0.44,0.25,0.83,0.28,0.44,0.39,0.5,0.44,0.5,0.44,0.5,0.5,0.39,0.5,0.28" y="390.1" x="361.9,365.5,367.5,374.2,376.4,379.9,383.0,387.0,390.6,394.6,398.1,402.1,406.1,409.3,413.3" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">J Microencapsul</text>
  <text svgx:width="0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.33,0.5,0.33,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="390.1" x="415.5,417.5,419.5,423.5,427.5,431.5,435.5,437.7,441.7,445.7,448.4,452.4,455.0,457.3,461.3,465.3,469.3,473.3,477.3,481.3,485.3" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. 2010;27(8):735–746.</text>
  <text svgx:width="0.25,0.5,0.5,0.25,0.25,0.55,0.67,0.5,0.28,0.5,0.5,0.72,0.39,0.5,0.28,0.25,0.55,0.61,0.25,0.25,0.55,0.56,0.44,0.44,0.44,0.44" y="400.1" x="304.6,304.6,308.6,312.6,314.6,316.6,318.6,323.9,327.9,330.2,334.2,338.2,343.9,347.0,351.0,353.3,355.3,355.9,360.8,362.8,364.8,365.5,369.9,373.5,377.0,380.6" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> 27. Chibowski E, Szcze</text>
  <text svgx:width="0.39" y="400.1" x="384.1" style="fill:rgb(23,22,21);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ś</text>
  <text svgx:width="0.25,0.55,0.72,0.25,0.25,0.55,0.61,0.44,0.28,0.44,0.25,0.55,0.5,0.5,0.28,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.5,0.33,0.33,0.44,0.44,0.44,0.25,0.55,0.44,0.5,0.44,0.33,0.5,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.56,0.56,0.67,0.25" y="400.1" x="387.2,389.2,389.9,395.7,397.7,399.7,400.3,405.2,408.8,411.0,414.6,416.6,417.2,421.2,425.2,427.4,431.0,435.0,437.2,439.4,443.0,445.2,447.2,447.9,451.4,455.4,459.4,461.4,462.1,465.2,469.2,471.8,474.5,478.1,481.6,485.2,487.2,487.8,491.4,495.4,498.9,501.6,505.6,509.1,511.1,511.8,515.8,518.5,520.5,521.1,526.9,531.3,535.8,541.1" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> A. Zeta potential and surface charge of DPPC </text>
  <text svgx:width="0.44,0.5,0.5,0.25,0.55,0.72,0.72,0.56,0.67,0.25,0.55,0.28,0.28,0.5,0.5,0.39,0.5,0.78,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.44,0.39,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.56,0.61,0.67,0.25,0.55,0.44,0.5,0.44,0.5,0.78,0.44,0.25,0.25" y="410.1" x="318.6,322.2,326.2,330.2,332.2,333.2,339.0,344.8,349.2,354.6,356.6,357.6,359.8,362.0,366.0,370.0,373.2,377.2,383.4,387.0,390.1,392.1,393.1,395.3,399.3,401.3,402.3,404.6,408.6,412.1,414.1,415.1,419.2,421.8,425.4,428.5,432.1,436.1,439.6,443.2,445.2,446.2,450.2,452.9,454.9,455.9,460.3,465.2,470.6,472.6,473.6,477.2,481.2,484.7,488.7,495.0,498.5,500.5" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">and DOPC liposomes in the presence of PLC enzyme. </text>
  <text svgx:width="0.61,0.5,0.39,0.5,0.39,0.5,0.28,0.28,0.5,0.5" y="410.1" x="503.5,508.4,512.4,515.5,519.5,522.7,526.7,528.9,531.1,535.1" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS-Italic;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Adsorption</text>
  <text svgx:width="0.25,0.25" y="410.1" x="539.2,541.2" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. </text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.33,0.5,0.5,0.5,0.33,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="420.1" x="318.6,322.6,326.6,330.6,334.6,336.8,340.8,344.8,347.5,351.5,355.5,359.5,362.2,364.4,368.4,372.4,376.4,380.4,384.4,388.4,392.4" style="fill:rgb(23,22,21);font-family:TimesNewRomanPS;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2016;22(4–6):755–765.</text>
 </g>
</svg>
